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ADCC, antobody-dependent cell-mediated cytotoxicity
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APC, antigen-presenting cells
BFGF, basic fibroblast growth factor
BIR, baculovirus IAP repeat
BMBM marrow-derived macrophages
BRASIL, Biopanning and rapid analysis of selective interactive ligands
CAD, caspase-activated DNase
CARD, caspase-recruitment domain
CAM, cell adhesion molecules
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Cdk, cyclin-dependent kinase
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DED, death effector domain
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EGF, epidermal growth factor
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ERK, extracellular-signal-regulated kinase
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FGF, fibroblast growth factor
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FN, fibronectin
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GEMM-CFU, granulocyte-megakaryocyte-macrophage colony-forming unit
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MMP, matrix metalloproteinases
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PGE, prostaglandin
PI3K, phosphatidylinositol-3 kinase
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1. CELLS: MACROPHAGES AND
ENDOTHELIAL CELLS
1.1 Hemangioblasts: a common progenitor
for macrophages and endothelial cells
The simultaneous appearance and close
apposition of nascent endothelial and blood cells in
mammalian embryos suggest that they may share a
common progenitor. Hematopoietic and endothelial
cell development has been extensively
characterized in the mouse, where hematopoiesis
and vasculogenesis can be identified in blood
islands of the extraembryonic yolk sac (YS) (Choi
et al., 1998). The blood islands consist of nucleated
erythroid cells surrounded by ECs. Macrophage
progenitors are produced in the YS, and mature
macrophages subsequently disperse throughout the
embryo by physical migration before circulation
begins. Early blood and endothelial precursors
share a similar pattern of gene expression, with
both lineages expressing CD34, GATA-2, LMO-2,
and SCL (Keller et al., 1999) and receptor tyrosine
kinases: vascular endothelial growth cell receptor-2
VEGFR-2 (Flk-1), Tie-1, Tie-2, (Yano et al., 1997).
Mouse embryonic stem cells cultured under
specific conditions express VEGFR-2 and produce
clonal populations of blood and ECs (Keller et al.,
1999; Nishikawa, 2001). Targeted disruption of the
murine VEGFR-2 gene results in catastrophic
defects in both YS hematopoiesis and
vasculogenesis, suggesting that signaling through
VEGFR-2 is important for hemangioblast
development (Figure 1).
Figure 1. Schematic view of primitive and definitive
hematopoietic development in the developing embryo (Choi,
2002).
Although formally not proven from clonal
studies, together these data support the
development of YS blood and blood vessels from a
common hemangioblastic progenitor (Traver et al.,
2002). The concept of hemangioblast has gained
support from the observation that hematopoietic and
endothelial lineages share expression of a number of
different genes, known to be expressed in ECs and
also expressed in early hematopoietc progenitors.
1.2 Macrophages
Macrophages are members of the mononuclear
phagocyte system that also includes monoblast and
monocytes, which have phagocytosis as their primary
function. Macrophages play an important role in host
development and physiology, and pathogenesis of
many infectious and degenerative disease processes.
Macrophages are motile cells that typically appear at
inflammatory sites within 24 to 48 hours. They are
relatively long-lived cells that exhibit continuous
secretory activity, such as tumor necrosis factor-a
(TNF-a), interleukin (IL)-1b , IL-6, etc, during
inflammatory processes, enabling them to destroy a
range of cells, antigens, and pathogens (Nathan,
1987, Laskin and Laskin, 1997). Macrophages are
also highly phagocytic cells, readily engulfing and
digesting a variety of substances including viruses,
bacteria, red blood cells, tissue and cellular debris,
and some tumor cells (Johnson, 1988). Despite their
origin from a common-bone-marrow progenitor
population (Van Furth, 1982), macrophages display
considerable tissue heterogeneity. Moreover, even
within tissues, there appear to be subpopulations of
macrophages that exhibit unique characteristics.
Studies suggest that the microenvironment of a tissue
regulates the phenotype of these cells.
1.2.1 Macrophage origin
All blood cells are derived from a small common
pool of totipotent cells, called hematopoietic stem
cells, located in the bone marrow. The process is
s t r ic t ly regulated by the hematopoietic
microenvironment, which includes stromal cells,
extracellular matrix molecules and soluble regulatory
factors. Several experimental in vitro assays have
been developed for the study of hematopoietic
differentiation and have provided valuable
information on the stroma, which includes, among
other cell types, macrophages, fibroblasts,
adipocytes, and ECs.
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In bone marrow, IL-1 and IL-3 and/or IL-6
induce heteromitosis in stem cells. This division
gives rise to a new stem cell and a pluripotent
myeloid cell, also referred to as granulocyte-
erythrocyte-megakaryocyte-macrophage colony-
forming unit (GEMM-CFU). In the presence of IL-
1 and/or IL-3, this precursor is committed to
becoming a progenitor of both macrophages and
granulocytes known as granulocyte-macrophage
colony-forming unit (GM-CFU). Thus, both
lineages are closely bound together throughout
hematopoiesis and commonly referred to as a
myelomonocytic lineage. At this point, IL-3 and
granulocyte-macrophage colony-stimulating factor
(GM-CSF) induce proliferation of these myeloid
precursors, whereas macrophage colony-
stimulating factor (M-CSF) induces not only their
proliferation but also their differentiation to
monocytic precursor (Figure 2). The first cell from
the terminal monocytic stage that can be detected
easily is the promonocyte, which shows a limited
phagocytic capability. Maturation of promonocytes
and the subsequent generation of monocytes also
require the presence of M-CSF. Monocytes are
generally smaller (10 to 15 µm) than their immediate
precursor, but they have a well-developed lysosomal
system and enhanced phagocytic capability. A
delicate balance should be maintained between
growth factors (M-CSF, GM-CSF and IL-3)
produced by their own proliferating cells and the
inhibitor agents such as prostaglandin E2, interferon
(IFN) a /b and lactoferrin for basal monocyte
generation (Celada, 1994; Valledor et al., 1998).
Mononuclear phagocytes are developed in the
bone marrow. From there they are released into the
blood and then migrate through the blood-vessels
walls by means of the interaction of adhesion
molecules that allow them to stick to the
endothelium, causing the bound monocytes to crawl
between the capillary ECs into the tissues. Once
settled in the tissue, they differentiate to macrophages
by growing and increasing their lysosomal content,
the amount of hydrolytic enzymes, the number and
size of mitochondria, and the extent of their energy
metabolism (Alberts, et al., 1994; Parslow et al.;
Valledor et al., 1998). However, although
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macrophages have the same origin, their function
depends on the tissue in which they reside.
1.2.2 Macrophage heterogeneity
Macrophage heterogeneity is a well-
documented phenomenon, perhaps first observed
by Metchnikoff, who described a progression of
infiltrating cell types in inflammatory exudates.
Macrophages are a heterogeneous population
differing in their site of location, morphology and
function. However, most macrophages are large
cells (20 to 80 µm in diameter). Macrophages are
long-living cells and may survive for months in the
tissues. The nomenclature of individual
macrophage types (particularly inflammatory) is
rather confusing and terms such as stimulated,
activated, induced, elicited etc., are often used
interchangeably. Basically, two main macrophage
groups can be distinguished: res iden t and
inflammatory macrophages. They are present in
connective tissue and around the basement
membrane of small blood vessels and are
particularly concentrated in the liver (Kupffer
cells), alveolar spaces of the lung (alveolar
macrophages), and linings of splenic and lymph-
node medullary sinusoids, where they are
strategically localized to filter foreign material.
Other examples of macrophages are Langerhan’s
cells in the skin, mesangial cells in the kidney
glomerulus, brain microglia, and osteoclasts in
bone. In general, macrophages are characterized
morphologically by an enlarged horseshoe-shaped
nucleus, significant rough-surfaced endoplasmic
reticulum, and large numbers of mitochondria and
cytoplasmic vacuoles, although these characteristics
vary depending on the tissue origin of the cell.
The major functions of macrophages are the
ingestion of particles, endocytosis, digestion of
these particles by lysosomes, and secretion of an
impressive array of substances that participate in
defensive and reparative function. Macrophages
ingest a particle by surrounding it with thin
extensions of the cell surface called “false hands”,
or pseudopods, that ultimately fuse, isolating the
particle within a phagocytic vacuole (phagosome).
Next, lysosomes fuse with the phagocytic vacuole
and digest the contents with a large number of
different enzymes such as acid phospha-tases,
ribonucleases, deoxyribonuclease, proteases,
sulfatases, lipases, and b - glucuronidase.
Macrophages are antigen-presenting cells and also
participate in cell-mediated resistance to bacteria,
viruses, protozoa, fungi, and metazoa; in cell-
mediated resistance to tumors; and in extrahepatic
bile production, iron and fat metabolism, and the
destruction of aged erythrocytes. Macrophages can
also destroy pathogens without directly targeting
them. By moving to an affected area, macrophages
can be stimulated to release chemicals toxic to
pathogens. A number of oxygen-and nitrogen-related
compounds could poison most pathogens.
Because macrophages are responsible for
numerous inflammatory processes, it becomes
important to distinguish between normal or steady-
state haematopoiesis and induced haematopoiesis
associated with immunological challenge. Production
of the macrophage lineage from bone-marrow
progenitors is normally controlled by M-CSF, which
is constitutively produced by many cell types. In
response to invasive stimuli and inflammation,
monocyte numbers increase dramatically, as do
serum levels of M-CSF. In addition, GM-CSF
appears in the serum. Although there appears to be a
large overlap of macrophage progenitors able to
respond to M-CSF or GM-CSF, the very different
structures and signal-transduction mechanisms of the
receptors for M-CSF and GM-CSF suggest that the
differentiation pathways they initiate would be
dissimilar.
M-CSF-derived macrophages are larger, have a
higher phagocytic capacity, and are highly resistant
to infection by vesicular stomatitis virus compared to
GM-CSF-derived macrophages. Conversely, GM-
CSF-derived macrophages are more cytotoxic against
TNF-a-resistant tumor targets, express more major
histocompatibility complex (MHC) class II antigens,
more efficiently kill Listeria monocytogenes, and
constitutively secrete more prostaglandin-E.
The diversity of the macrophage’s morphologic
characteristics extends to its metabolism, which also
varies according to this cell’s functional activity and
environment. Functional heterogeneity results from
the spectrum of maturational states in a given isolate
because of the influx of monocytes and/or local
proliferation. Because macrophage function is
dependent in part on signals received from the
immediate microenvironment, it is suggested that
macrophage heterogeneity may arise from unique
conditions within specific tissues. Obviously, the
sterile, anaerobic environment of the spleen or
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peritoneum will impart different constraints on
resident macrophages than does the aerobic
environment of the alveolar macrophage, which
contains numerous external factors.
1.2.3 Macrophage function
Macrophages are involved at all stages of the
immune response and are also important effector
cells in both innate and adaptive immunity. Their
effector functions on innate immunity are to
phagocytose microbes and produce cytokines that
recruit and activate other inflammatory cells.
Macrophages serve numerous roles in the effector
phase of adaptive immune responses. In cell-
mediated immunity, antigen-stimulated T cells
activate macrophages to destroy phagocytosed
microbes. In humoral immunity, antibodies coat, or
opsonize, microbes and promote the phagocytosis
of the microbes via macrophage surface receptors
for antibodies.
Macrophages act as a rapid protective
mechanism that can respond before T cell-mediated
amplification has taken place. Activated
macrophages play a key role in host defense against
intracellular parasitic bacteria, pathogenic protozoa,
fungi and helminthes, as well as against tumors,
especially metastasizing tumors. After
phagocytosis, macrophages prevent intracellularly
parasitic organisms from replication by at least three
ways: first, intracellular environment is unsuitable for
microbial reproduction due to low pH and lack of
nutrients in a phagolysosome. Second, a toxic
reaction may be activated against dividing organisms.
This includes reactive oxygen intermediates,
hypochlorite, nitric oxide (NO), myeloperoxidase,
neutral proteases and lysosomal hydrolases; and
third, macrophages may also produce microbiostatic
effector molecules at a steady-state and thus maintain
intracellular micro-organisms in the nonreplicating
state. This latent infection is generally observed only
in individuals whose macrophages cannot be
sufficiently activated (Abbas, 1994; Gordon, 1995).
Macrophages are also important killer cells; by
means of antibody-dependent cell-mediated cytotoxi-
city (ADCC) they are able to kill or damage
extracellular targets. They also take part in the
initiation of T-cell activation by processing and
presenting antigen. Activated macrophages become
more efficient antigen-presenting cells (APCs)
because of increased levels of molecules involved in
antigen processing, such as components of the
proteasome and cathepsins, increased surface
expression of MHC class II molecules and
costimulators, and production of cytokines, such as
IL-12, which stimulate T lymphocyte proliferation
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and differentiation (Figure 3).
Finally, macrophages are central effector and
regulatory cells of the inflammatory response.
Activated macrophages stimulate acute
inflammation through the secretion of cytokines,
mainly TNF, IL-1 and chemokines, and short-lived
lipid mediators such as platelet-activating factor,
prostaglandins, and leukotriens. To fulfill these
functions, macrophages in their activated state are
able to produce more than 100 different substances
(Table 1).
Macrophages secrete not only cytotoxic and
inflammation-controlling mediators but also
substances participating in tissue reorganization.
They include enzymes, such as hyaluronidase,
elastase, and collagenase, inhibitors of some of them
(antiproteases), regulatory growth factors and others.
Hyaluronidase, by destroying hyaluronic acid, an
important component of connective tissue, reduces
viscosity and thus permits greater spreading of
material in tissue spaces. Hyaluronidase is therefore
sometimes designated as the spreading factor.
Extracellular matrix proteins and receptors in apoptosis
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Elastase and collagenase are enzymes capable of
splitting collagen and elastin, the basic members of
connective proteins.
1.3. Endothelial cells
The endothelium has long been viewed as an
inert cellophane-like membrane that lines the
circulatory system, with its primary essential
function being the maintenance of vessel-wall
permeability. As such, endothelial cells (ECs) were
thought to participate in tissue reactions, essentially
as targets for injurious agents. This point of view
has changed radically; it is now evident that the
endothelium is a dynamic, heterogeneous,
disseminated organ that possesses vital secretory,
synthetic, metabolic and immunologic functions
(Fishman, A.P., 1982).
EC coat the entire inner surface of the blood
vessels in an adult human. The endothelium is
composed of approximately 1 to 6 x 1013 cells,
weighs approximately 1 kg, and covers a surface
area of approximately 1 to 7 m2 (Augustin HG et
al., 1994). Depending on the type of vessel (artery,
vein, capillary) and vascular bed, activated ECs that
are migrating and proliferating, forming
anastomotic connections with each other, become
variably surrounded by layers of periendothelial
cells - pericytes for small vessels and smooth
muscle cells for large vessels. EC are the key
cellular mediators of vascular development, and the
embryonic vascular system is critical for the
transport of metabolic waste, nutrients, and
humoral signals to and from developing tissues
through the presence of membrane-bound receptors
for numerous molecules, as well as through specific
junctional proteins and receptors that govern cell-
cell and cell-matrix interactions. New vessels in the
adult arise mainly through angiogenesis, although
vasculogenesis also may occur. The existence of a
postnatal vasculogenesis is supported by the
evidence that both ECs and endothelial precursor
cells co-exist in the circulation. Moreover, EPCs
are also recruited to sites of neovascularization in
mature mammals from a circulating, marrow-
derived population of progenitor cells (Asahara et
al., 1997). Although circulating ECs have been
suspected of having the capacity to colonize
vascular grafts (Shi, 1992; Rafii, 2000), the
contribution of these cells to postnatal
vasculogenesis is not known. The possibility that
endothelial precursor cells, showing properties
similar to those of embryonic angioblasts, persist into
adult life, whereby they may circulate, differentiate,
and contribute to the formation of new blood vessels,
remains to be determined.
1.3.1 Origin of endothelial cells
The relationship between hematopoietic cells and
ECs has been seen as an indication that a common
progenitor, the hemangioblast (Choi et al., 1998,
gives rise to both cell types in the yolk sac, the initial
site of hematopoiesis and blood-vessel formation
during mammalian development. Angioblast-
circulating endothelial precursor cells exist in adults
humans; they are defined as a cell type that has the
potency of differentiating into ECs but has not yet
acquired all the characteristic markers (Table 2). An
important and still incompletely solved question is
how ECs take different pathways of differentiation.
One of the determinants is the local environment in
which ECs differentiate, and especially their
interaction with surrounding cells. This interaction
may occur through the release of soluble mediators,
cell-to-cell adhesion, and the synthesis and
organization of matrix proteins on which the
endothelium adheres and grows. The activation of
flk-1, which is the VEGF receptor tyrosine kinase
expressed in EC, triggers the differentiation of
angioblast in the endothelial-specific pathway
(Millauer et al., 1993). Fibroblast growth factor
(FGF) may act at the level of hemangioblasts or at an
earlier stage, but it is not responsible for differential
commitment into endothelial or hematopoietic
lineage.
Embryonic ECs seem particularly "plastic." Most
of the specialized characteristics of ECs are induced
during development, whereas adult endothelium is
not equally susceptible to differentiation factors
(Risau W. 1995; Engelhardt and Risau W 1995).
Despite its stable constitutive properties, the adult
endothelium can reversibly change its functions on
activation. For instance, exposure of EC to
inflammatory cytokines, such as IL-1 and TNF, or to
growth factors, such as VEGF or FGF, induces a
complex functional reprogramming, which implies
the neosynthesis of some genes and the repression of
others. ECs can be activated several times during
their life span by the same or different cytokines and
thereby display different and reversible phenotypes
(Mantovani et al., 1992). Cell senescence may also
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influence endothelial responses. Unlike young
endothelium, senescent ECs display different
properties, such as an
Table 2. Surface markers of endothelial cells.
Surface
markers
Endothelial
progenitor
cell
Vessel wall
endothelium
VEGFR-2 (flk-1) + +
VEGFR-3 (flt-4) ? +
VEGFR-1 (flt-1) ? +
Tie-2 ? +
VE-cadherin + +
CD34 ++ +
Ac. LDL uptake + +
PECAM (CD31) + +
AC133 + -
vWF - +
CD105 + +
CD36 ? +
PIH12 (CD146) ? +
Trombomodulin ? +
E-selectin ? +
Weidel-Palade
bodies
+ +
Tie-1 + +
Thy-1 + +
UEA-1 + +
av integrin + +
inability to properly respond to growth factors due
to defective signaling pathways. (Garfinkel et al.,
1996) The actual mechanism regulating cell
senescence is still incompletely understood; current
research suggests a correlation between senescence
and intracellular IL-1 accumulation; elevated levels
of intracellular IL-1 in the senescent human
umbilical     vein     endothelial cells (HUVEC)
population are biologically active and may be
involved in the induction of the senescent HUVEC
phenotype (Garfinkel et al., 1997). In addition, the
ability of IL-1 to promote tissue degradation appears
to be intimately associated with its ability to
stimulate the synthesis of matrix metalloproteinases
(MMPs) such as collagenase and stromelysin; and IL-
1 not only induces tissue destruction, but also inhibits
tissue repair (Ganu et al., 1998).
1.3.2 Endothelial cell heterogeneity
ECs are a heterogeneous population (Table 3).
There are differences between the endothelium of
different species, between large and small vessels and
between ECs derived from various microvascular
endothelial beds. Typical ECs are elongated
(approximately 30 µm long, and 0.3 µm deep) and
carry a negatively charged glycosaminoglycan layer
(approximately 10 nm deep) on their surface (Ribatti
et al, 2002, review). Many human vascular diseases
are exquisitely restricted to specific types of vessels.
For example, the contribution of platelets to the
pathogenesis of arterial and venous thrombosis
differs, as does the susceptibility of these two types
of vessels to atherosclerosis. Tumor cells may show
similar predilection to metastasize through particular
vascular beds (Zetter, 1997). Even when systemic
risk factors are clearly evident, such as is the case
with inherited disorders of lipoprotein metabolism or
proteins that control coagulation, there is marked
regional variation in disease expression. Furthermore,
clinical events such as thromboses are generally
episodic and often localized to single vessels. The
basis for variation is poorly understood, but may lie,
in part, in the heterogeneity of ECs themselves
(Augustin et al., 1994; and McCarthy et al., 1991 for
reviews).
Variation in the appearance of capillary
endothelium from different vascular sites has long
been recognized and appears well suited to postulated
differences in function. On the basis of morphology,
microvascular endothelium in normal adult
organisms has been divided into different
phenotypes: continuous, fenestrated, and
discontinuous (Table 4).
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ECs line vessels in every organ system and
regulate the flow of nutrient substances. Continuous
endothelium is characteristic for the brain and
retina, where lined ECs are connected by tight
junctions that help to maintain the blood-brain
barrier: the liver, spleen, and bone marrow
sinusoids are lined by discontinuous ECs; the
intestinal villi, endocrine glands, and kidneys are
lined by fenestrated ECs that facilitate selective
permeability required for efficient absorption,
secretion, and filtering (see Dejana, 1996 for
review). Venules have the most and arterioles the
least elaborated junctional system, whereas
capillaries have no communicating junctions and
can also vary from ECs > 2 µm (thick) to ECs < 1
µm (thin; Simionescu et al., 1975, 1976).
EC from diverse tissues are also heterogeneous
with respect to their surface phenotype and protein
expression. Among many others, the following
examples illustrate the heterogeneity of ECs at the
protein expression levels: 1) von Willebrand factor
(vWF), used commonly as a marker for ECs, is not
expressed uniformly in cells from all types of vessels
(Kumar et al., 1987; Turner RR et al., 1985); 2) the
expression of tissue type plasminogen activator is
limited in vivo to approximately 3% of vascular ECs
(Levin and Osborn, 1997), and the constitutive
expression of u-PA is reportedly confined to renal
ECs (Wojta et al., 1989; Louise and Obrig, 1994),
which are also uniquely susceptible to injury by
verotoxin (Obrig et al., 1994); 3) the induction of
tissue factor after infusion of cytokines or endotoxin
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is similarly restricted to specific vessels (Drake et
al., Am J pathol 1993). Microvascular ECs cultured
from the brain, liver, and other organs each express
distinct patterns of cell-surface markers, protein
transporters, and intracellular enzymes (Owman
and Hardbeo, 1988). These tissue-specific
phenotypic differences can be maintained for some
time under identical tissue-culture conditions (Grau
et al., 1997; Smith et al., 1996). Distinct subsets of
EC often exist within a single organ. In situ studies
of adult human liver show two distinct sinusoidal
ECs phenotypes: hepatic periportal vessels express
PECAM-1 and CD34, whereas sinusoidal
intrahepatic ECs do not (Morin et al., 1984).
ECs can also acquire malignant properties.
They can form angiosarcomas, which are highly
invasive and usually fatal. There is strong evidence
that Kaposi’s sarcoma has an endothelial origin;
however, it expresses markers from both ECs and
macrophages, suggesting that it may originate from
a special type of EC similar to macrophages present
in lymph nodes (Uccini et al., 1994).
1.3.3 Endothelial cells’ function
General aspects of endothelial function are
regulating hemostasis, vascular tone and growth, as
well as the inflammatory response. A particular role
in inflammation is played by cell-adhesion
molecules (CAMs), expressed both on endothelial
and blood cells. It had been shown that cytokine-
induced up-regulation of CAM in the endothelium
may involve signal-transduction pathways. Finally,
the phenomenon of angiogenesis is a characteristic
of EC activity, with central importance on both
physiology and pathology and the ability of
individual ECs to form vessel-like structures.
Likewise, the role of ECs in pathological processes
as diverse as atherosclerosis, tumor intravasation
and multiple organ failure depends of the
physiology and cell biology of the endothelium.
Vascular development consists of two different
processes, vasculogenesis and angiogenesis. In
both, bidirectional signaling between ECs and the
surrounding mesenchymal cells is critical (Folkman
and DAmore, 1996). The earliest stages of vascular
development, termed vasculogenesis, include the
differentiation, expansion, and coalescence of
vascular endothelial cell precursors (angioblasts)
that migrate to discrete locations to form the initial
vascular network (Risau, 1995; Conway et al., 2001).
Angiogenesis is a biological process by which new
capillaries are formed from pre-existing vessels. It
occurs in physiological and pathological conditions,
such as tumors, where a specific critical turning point
is the transition from the avascular to the vascular
phase. (Figure 4). When angiogenesis is initiated,
however, there is a rapid change in the EC-
extracellular matrix (ECM) interactions (Conway et
al., 2001). The ECs of an angiogenic sprout need to
degrade and invade through different types of ECM,
detach from various ECM components, and attach to
new ones. With alterations in the ECM and ECs
invasiveness, the ECs need to receive the appropriate
signals from changing microenvironment. These
functions are carried out by specific classes of
molecules: those that mediate the recognition of
ECM components by ECs, i.e. endothelial matrix
receptors, and those that participate in the proteolytic
degradation of the components, i.e., matrix
proteinases.
Figure 4. Differentiation of ECs. Putative endothelial stem cells
migrate, proliferate and differentiate during vasculogenic and
angiogenic processes to form the various EC phenotypes found in
different vascular beds. Stimulation of resting ECs leads to the
situation-specific expression of ECs molecules, which are
characteristic for the activated phenotype. Likewise,
transdifferentiation of ECs characterizes the process through which
a specific constitutive EC phenotype is altered in response to
changes in the microenvironment that control a specific
constitutive phenotype.
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Differentiation of the EC phenotypes appears
to follow similar mechanisms to the differentiation
of hematopoietic cells, with the exception that ECs
maintain transdifferentiating competence.
ECs, the major cellular components of the
vasculature, are metabolically active cells capable
of the synthesis and secretion of a variety of
biologically active molecules important in
regulating vascular tone and blood flow, in the
modulation of inflammatory and immune
responses, and regulating vascular growth. In
particular, ECs synthesize and release a number of
growth factors including IL, colony stimulating
factors (CSF), and IFNs, to modulate the growth
and proliferation of hematopoietic cells. EC also
synthesize matrix components to induce the
adhesion of blood cells to vascular EC for the
migration of these cells to peripheral organs.
1.3.3.1 The activated phenotype of endothelial
cells
EC activation in response to the micro-
environment is associated with a number of distinct
phenotype changes that, much like the
transdifferentation process of the constitutive
phenotype, serve their need to locally adapt to
specific functional requirements (Figure 5).
Surface molecules associated with the activated
cytokine-inducible endothelial phenotype play a
critical role in pathological conditions, including
inflammation, tumor angiogenesis, and wound
healing. Early consequences and clinical signs of
endothelial activation and damage result from
microvascular coagulopathy, increased microvascular
permeability, leukocyte adhesion and migration,
activation of reactive oxygen species, vasodilatation,
and cytokine production. Endothelial activation and
damage may occur not only during sepsis but also in
all clinical settings that involve systemic
inflammation and biochemical alterations such as
shear stress and increased hydrostatic pressure
(Reinhart K et al., 2002). The cytokine-induced
phenotype of ECs during inflammation has been
characterized in the last few years. Inducible EC
adhesion molecules, such as E-selectin, P-selectin,
vascular cell adhesion molecule-1 (VCAM-1) and
intercellular adhesion molecule-1 (ICAM-1) are
expressed on the cell surface following cytokine
exposure enabling them to direct circulating cells to
sites of inflammation. Angiogenesis is another
example of EC activation that induces such changes.
It involves degradation of ECM combined with
sprouting and migrations of ECM from existing
capillaries. One of the first events that occurs is the
weakening of stable cell-cell contacts between ECs in
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the parent vessels and the transition of ECs from
quiescent stationary to dynamic migratory
(Ausprunk and Folkman, 1997). The regulation of
motility and adhesion of ECs to the underlying
ECM and each other is therefore an important
aspect of angiogenesis. Furthermore, areas of
replicating ECs exhibit increased vascular
permeability (Padera et al., 2002; Caplan and
Schwartz, 1977), a critical step in angiogenesis.
Adhesion molecules are involved in shaping the
angiogenic phenotype of ECs (Brooks et al., 1994).
1.3.3.2 Endothelial cell-cell interactions and
vessel formation
Two major processes-vasculogenesis and
angioge-nesis- are responsible for blood-vessel
formation in vivo (Hanahan, 1997; Carmeliet and
Jain, 2000; Patan, 2000; Conway et al., 2001).
These events require EC interactions with ECM
through integrins, and signaling events involving
cytoskeletal elements that control EC shape and
cell-cell interactions that dictate the 3D structure of
tubes of the blood vessels. Cellular activities
associated with invasion implicate reduced cell-cell
adhesion, altered cell-matrix adhesion, migration,
ectopic survival, and lysis of extracellular matrix.
Endothelial cell contacts control the permeability of
the blood-vessel wall. This allows the endothelium
to form a barrier for solutes, macromolecules, and
leukocytes between the vessel lumen and the
interstitial space. The formation and maintenance of
ECs contacts require the complex interplay of
plasma membrane proteins, cytoskeleton
components, and associated signaling molecules.
Some of these molecules are specifically expressed
in specialized cellular junctions. EC-cell contacts
do not show a clear spatial organization and
morphological differentiation with respect to tight
junctions, desmosomes, and adherens junctions.
The endothelial junction of mammalian blood
vessels represents a continuous belt system related
to but different from the adherens junctions of polar
epithelial cells (Franke et al., 1988). In such
junctions, the adherens junction protein vascular
endothelial (VE)-cadherin and the desmosomal
protein desmoplakin can be co-localized
(Kowalczyk et al. 1998;). Classical desmosomes
are not present in ECs (Schmelz and Franke, 1993).
Cell contacts seem to be present along the complete
region of the lateral membranes between
endothelial cells.
Cell-cell adhesion is mediated by a distinct series
of cell-surface receptors that includes PECAM-1
(Albelda et al., 1991), a member of the Ig
superfamily, and VE-cadherin (Risau and Flamme,
1995). ECs express two isoforms of PECAM that
mediate cell adhesion. They differ in their
requirement for divalent cations and sulfated
proteoglycans. VE-cadherin, also known as cadherin-
5 and found almost exclusively on ECs, promotes
cell-cell adhesion by a calcium-dependent homotypic
mechanism (Dejana, 1996), i.e., in the presence of
calcium, VE-cadherin from one cell binds to the VE-
cadherin expressed on an adjacent cell. Beyond cell-
cell adhesion, these molecules are important signal-
transduction ligands, which influence diverse cellular
processes, including proliferation (Conacci-Sorell et
al., 2002) and EC survival (Carmeliet et al., 1999).
1.3.3.3 Endothelial cell-matrix interactions
The ECM is a key player in activities crucial for
normal cell behavior and tissue maintenance
(Lukashev and Werb , 1998). In invasion, the ECM
and its cellular integrin and nonintegrin receptors are
implicated as a barrier, a signal, and a substrate for
invasion; as a source of growth and motility factors;
and as a regulator of survival (Van Hoorde et al.,
2000). For cancer-cell migration, a dynamic
formation and dissolution of cell-substrate contacts
are needed; and ECM receptors are expected to have
a dual function as they provide adhesion to the matrix
necessary for migration, as well as arrest of cells
inside the matrix. To coordinate all these functions,
multiple extracellular and intracellular networks as
well as fine-tuning signaling are necessary.
Structurally, cell-substrate adhesion is manifested by
smaller focal complexes at the leading edge of
migratory cells, larger focal adhesions at the end of
actin stress fibers all over the surface of static cells,
and hemidesmosomes between epithelial cells and
the basement membrane. The interactions of ECs
with the ECM can regulate the ability of ECs to form
capillary-like tubes. For example, HUVEC exposed
to transforming growth factor-b (TGF-b) grow as a
rapidly dividing monolayer if cultured on a flat
surface coated with type I collagen (Sankar et al.,
1996). However, under similar TGF-b exposure, but
within a type I collagen gel, ECs spontaneously
organize into capillary-like tubules and continue to
divide. Studies indicate the ECM receptors
expressed by EC are critical to maintain a proper ECs
function. The best-studied family of receptors that
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mediate cell-matrix interactions are the integrins
(Schwartz et al., 1995), which serve both a
tethering and an information transfer function.
Integrin-ligand binding triggers cytoskeletal
organization at specific sites on the surface
membrane to facilitate cell movement or maintain
tissue stability. Binding also activates intercellular
pathways that can result in either cell replication or
programmed cell death (Varner et al., 1995).
Together with these functions, ECs in their
activated state are able to produce chemokines that
allow a tight regulation of the microenvironment
(Table 5).
Cells express more than one integrin and the
combination of integrins expressed during
embryonic development is constantly changing,
suggesting that specific combinations are required
as development proceeds. Experimental results in
the developing mouse embryo suggest that
functional compensation by integrins can occur
during embryogenesis.
Angiogenesis is stimulated by a shift in the
balance between angiogenic and antiangiogenic
factors and depends on specific molecular
interactions between the vessels. The formation of
new blood vessels, i.e., angiogenesis, is an
important phenomenon during normal development
and tissue repair, as well as during various
pathological processes, such as tumor growth and
ocular neovascularization (Folkman, 1995;
Carmaliet and Jain, 2000). ECs and their
surrounding microenvironment are composed of
neighboring cells and the ECM, which consists of a
network of molecules composed primarily of type
IV collagen, laminins, and heparan sulfate
proteoglycans.
2. EXTRACELLULAR MATRIX
Cells of higher multicellular organisms are
surrounded by a highly organized matrix of proteins
and glycoconjugates. The ECM was originally
defined morphologically as extracellular material
visible as fibrils or sheets in the electron microscope.
The understanding of ECM functions has been
enhanced in recent years by the discoveries of novel
extracellular matrix constituents, mapping sites
crucial for the interactions of ECM constituents with
each other and with cells, characterization of
proteases and protease inhibitors that regulate ECM
assembly, and turnover and identification of novel
receptors and signaling mechanisms that mediate
cellular responses in ECM constituents.
Matrix components include ligands that activate
intracellular signaling pathways within cells, thereby
regulating cell proliferation, survival, and
differentiation (Schwartz et al., 1995; Burridge and
Chrzanowska-Wodnicka, 1996; Kleiman and
Reichardt, 1996; Sanes, 1997; Wary et al., 1996).
These functions can be mediated not only through
interaction with cell receptors but also through direct
interaction with growth factors (Lopez-Casilla et al.,
1994; Kaname and Rouslahti 1996). The ECM
thereby helps regulate the special and temporal
properties of signals conveyed by these molecules.
Major constituents identified initially in the
ECMs included collagens, noncollagenous
glycoproteins, (i.e., fibronectin), and proteoglycans.
Organization of these components into a fibrillar
framework provides mechanical strength and
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elasticity for cell adhesion and migration.
2.1. Glycoproteins or noncollagenous
proteins
Many glycoproteins unique to vertebrates are
unusually large molecules with extended
conformations spanning distances of several
hundred nanometers. Two groups of glycoproteins
have been described according to function: the first
group includes the adhesive glycoproteins, such as
fibronectin, vitronectin and laminin, which form
connections between other ECM and cells via
specific integrin receptors; the second group
comprises the matricellular proteins, which are a
class of secreted proteins that interact with other
ECM constituents, and multiple specific cell
surface receptors, as well as growth factors, to
modulate cell-matrix interactions. This last group
includes osteopondin, tenascin, trombospondin and
secreted protein acidic and rich in cysteine
(SPARC) (Raines, 2000) (Table 6).
Table 6. Structural glycoproteins of the ECM
Glycoproteins
Adhesive glycoproteins
fibronectin
laminin
vitronectin
Matricellular proteins
 osteopontin
 SPARC
 tenascin
 thrombospondin
Fibronectin (FN) is one of the best-
characterized ECM proteins (Rouslahti, 1988;
Hynes, 1990; Springer, 1994). FNs are high-
molecular-weight glycoproteins found in many
ECMs and in blood plasma. They promote cell
adhesion and modulate cell morphology, migration
and differentiation and cytoskeletal organization.
They are composed of two similar subunits of
230-290 kDa joined by disulfide bonds at their
carboxyl termini. Each subunit is made up of a
series of repeating units that in turn form structural
and functional domains specialized for binding to
cell-surface integrin receptors or other ECM
molecules. The polymorphic nature of FN
molecules results from alternative splicing of the
transcript of a single gene. FNs have been found in
all major groups of vertebrates, but there are not
convincing reports showing that invertebrates have
FNs. Laminins represent a protein family of
heterotrimers primarily located in basement
membranes (Timpl and Brown, 1996). This family of
ECM molecules was first identified in mouse tumor-
cell lines. Major activities include the formation of
networks and filaments and binding to cells through
integrin and nonintegrin receptors. The latter
activities determine cell adhesion and migration,
differentiation, gene expression and cell fate. Another
adhesive glycoprotein, vitronectin (VN) is a
multifunctional 75 kDa glycoprotein that constitutes
the major adhesive component of serum, and permits
the attachment and spreading of cells propagated in
serum-containing media in culture (Felding-
Habermann and Cheresh, 1993). VN is present in the
supporting stroma of a variety of normal tissues but
not in the basement membrane per se. In vivo, the
physiological roles of VN have been shown to
include the regulation of thrombosis, fibrinolysis, and
complement-mediated cell lysis in the circulation.
There are several forms of matricellular proteins:
tenascins represent a family of large multimeric ECM
proteins, each consisting of identical subunits built
from variable numbers of repeated domains. These
include heptad repeats, epidermal growth factor
(EGF)-like repeats, FN type-III domains and a C-
terminal globular domain. The prototype of tenascins
is tenascin C, present in a large number of developing
tissues and it is also abundant in adult ligaments and
tendons. Tenascin C is overexpressed in many
tumors. SPARC binds both to extracellular matrix
proteins and to cells and thereby regulates cell-matrix
interaction. Addition of SPARC and SPARC-derived
peptides to cultured cells modulates cell spreading,
cell migration, cell-cell progression, and gene
expression.
The thrombospondins are a family of five
extracellular calcium- and glycosaminoglycan-
binding proteins that function during embryogenesis,
angiogenesis and wound healing (Bornstein, 1992;
Adams et al., 1995. Thrombospondins are trimeric
glycoproteins that appear to facilitate cell-to-ECM
contacts that regulate cellular migration, motility,
proliferation, and neurite outgrowth (Iruela-Arispe et
al., 1993). Osteopontin is a secreted acidic
glycoprotein normally found in mineralized matrices.
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In tissues undergoing inflammation, fibrosis,
oncogenesis, or dystrophic calcification,
osteopontin expression is increased due to novo
expression by macrophages, epithelial, tumor
and/or mesenchymal cell populations responding to
injury. In vitro, it has been shown that osteopontin
regulates cell adhesion, migration, and survival.
2.2. Collagens
The collagen matrix constitutes a major portion of
the vascular ECM and imparts blood vessels with
tensile. Collagenous proteins usually form
supramolecular aggregates (fibrils, filaments, or
networks), either alone or in conjunction with other
ECM components. Their major function is to
contribute to the structural integrity of the ECM, or
to help anchor cells to the matrix. The collagen
superfamily can be divided into several subfamilies
(Table 7) based on exon structures of the genes that
encode collagenous proteins, and functional
considerations. The fibrillar collagens are a major
component of the vascular matrix, and the most
abundant are types I and III collagen, which form an
interconnected network of cross-banded fibers along
with smaller amounts of type VI and XVIII collagen
associated with the fibers and the elastic lamellae in
the blood-vessel wall (Raines, 2000). Collagens are
not only essential for the mechanical resistance and
resilience of multicellular organisms, but are also
signaling molecules defining cellular shape and
behavior. The communication between collagens and
cells is achieved by cell-surface receptors. Three
types of cell-surface receptors for collagen are
known: integrins, discoidin domain receptors, and
glycoprotein VI. All three types independently trigger
a variety of signaling pathways upon collagen-
binding. Novel mechanisms of locally controlled
expression of collagen, collagen-binding receptors
and collagen-degrading proteases in the cellular
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microenvironment have recently been discovered
(Vogel, 2001).
2.3. Proteoglycans
Proteoglycans comprise a collection of
macromolecules that surround the plasma
membrane of a cell and constitute part of the
substrate upon which the cells are attached and
perform their major functions. These molecules are
a separate class of glycoproteins, and they are a set
of ubiquitous proteins found on cell surfaces or
within intracellular vesicles, and incorporated into
intracellular matrices. They are also found in
membrane spanning and soluble forms.
Proteoglycans are considered to be important in
cell-to-cell and cell-to-ECM adherence (Letourneu
et al., 1997), and as regulators of cell migration,
synaptogenesis, and plasticity (Bandtlow and
Zimmermann, 2000).
Proteoglycans are involved in maintaining the
transparency of the cornea, the tensile strength of
the skin and tendon, the viscoelasticity of blood
vessels, and the compressive properties of the
cartilage. In addition, proteoglycans play key roles
as storage depots for growth factors and cytokines;
and by virtue of their multifunctional properties,
they alter the biology of these factors. The growth of
the proteoglycan gene family has been astounding in
the past decade. Before the era of molecular cloning,
proteoglycans were named by the type of
glycosaminoglycan chain found on them, from where
they were isolated, and/or by distinguishing
biochemical features. Lately a classification for the
proteoglycans was based on the nature, overall
structure and biological properties (Iozzo and
Murdoch, 1996). According to this classification, the
proteoglycans are divided into three broad categories:
the small leucine-rich proteoglycans (SLRPs), the
hyalectans (proteoglycans interacting with
hyaluronan and lectins) and the basement-membrane
proteoglycans (Iozzo, 1998) (Table 8).
2.3.1. Small leucine-rich proteoglycans
(SLRPs)
SLRPs are small, ubiquitous proteoglycans
enriched in leucine with 24 amino acid tandem
repeats flanked by cysteine clusters. The prototype
member of the family is decorin. Based on their
protein and genomic organization, three classes of
SLRPs can be identified (Table 8). Essentially, they
are all characterized by a central domain containing
leucine-rich repeats (LRR) and flanked at either side
by small cysteine-clusters. Class I comprises decorin
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and byglican, which show the highest homology
(57% identity). Class II includes fibromodulin,
lumican, keratocan, and PRELP (~50% identity).
Class III comprises epiphycan and osteoglycin with
40% identity.
2.3.1.1. Decorin
Decorin is a small proteoglycan composed of a
38-kDa core protein usually modified with a single
chondroitin sulphate (bone) or dermatan sulphate
(most soft tissues) glycosaminoglycan chain and
two or three N-linked oligosaccharides. The protein
has four domains very well differentiated: domain
I, which contains the signal peptide and a
propeptide; domain II, which contains four evenly
spaced cys te ine res idues and the
glycosaminoglycan attachment site; domain III,
which comprises the 10 tandem repeats of ~25
amino acids characteristically rich in ordered
leucines (leucine rich repeats); and domain IV,
which contains a relatively large loop with two
cysteins residues (Iozzo, 1998) (Figure 6). The
most commonly cited functions of decorin are its
roles in collagen fibril assembly and stabilization,
as well as its ability to bind to TGF-b.
Figure 6. Schematic representation of the structural features of
decorin, the prototype member of the small leucine-rich
proteoglycans.
The decorin-induced effects are mediated, at
least in part, by a specific interaction between the
decorin protein core and the EGF receptor (EGFR)
(Moscatello et al., 1998; Iozzo et al., 1999). The
decorin protein core binds to a discrete region of
the EGFR, partially overlapping with but distinct
from the EGF-binding epitope (Santra et al., 2003).
This interaction triggers a signal cascade leading to
activation of mitogen-activated protein kinases
(Moscatello et al., 1998), mobilization of
intracellular calcium (Patel et al., 1998), up-
regulation of p21Waf1/CIP1 (Nash et al., 1999, De Luca
et al., 1996), and ultimately growth suppression
(Santra et al., 1995; Santra et al., 1997, Nash et al.,
1999). However, following a transient stimulation of
the EGFR kinase, decorin causes a sustained down-
regulation of the EGFR (Csordas et al., 2000) and
other ErbB members of receptor tyrosine kinase
(Santra et al., 2000), an action that would negatively
affect tumor growth. Interestingly, EGF suppresses
decorin expression in normal fibroblasts, suggesting a
negative feedback loop between growth-promoting
and growth-suppressing factors (Laine et al., 2000)
(Figure 7).
2.3.1.2. Effect of decorin on cell proliferation
One of the more interesting activities ascribed to
decorin is as a regulator of cell proliferation. Decorin
levels are elevated during quiescence (Asundin and
Dreher, 1992), and decorin expression is low in
actively proliferating or transformed cells (Coppock
et al., 1993), observations consistent with a role for it
in growth inhibition. Colon carcinoma cells
transfected with decorin become quiescent (arrest in
G1), lose their malignant phenotype (Santra et al.,
1995; Nash et al., 1999), and exhibit a marked up-
regulation of p21Waf1/Cip1 (De Luca et al., 1996)
(Figure 7). Decorin also suppresses the growth in
other tumor cells derived from genitourinary,
skeletal, cutaneous and bone-marrow tissues; and that
activity is independent of functional p53 (Santra et
al., 1997). Recently, decorin expression has been
shown in normal cells such as endothelial (Schonderr
et al., 2001), and mesangial cells (Abdel-Wahab et
al., 2002). Synthesis of decorin as well as type I
collagen is associated with endothelial cord and tube
formation in vitro and correlates with the cells'
functional state (Jarvelainen et al., 1992; Schönherr et
al., 2001).
The role of decorin as an antiproliferative agent
may be important in different disease states, such as
fibrosis and cancer. Indeed, decorin has been used as
therapeutic agent for reduction of matrix
accumulation in experimental glomerulonephritis in
rats (Isaka et al., 1996). The expression of decorin is
sufficient to induce differentiation of ECs and to
protect them from apoptosis, an important element
for the survival of the ECs during angiogenesis
(Schönherr, et al., 1999; Schönherr, 2001).
Furthermore, decorin expression is followed by an
up-regulation of cyclin-dependent kinase inhibitors
(DeLuca, et al., 1996), probably, as mentioned above,
via interaction with an EGFR family member
Introduction
18
(Moscatello et al., 1998). It is therefore also
involved in cell-cycle control.
2.3.1.3. Interaction of decorin with TGF-b
TGF-b is a multifunctional cytokine that
regulates a diverse range of processes important for
cell growth. It has been determined that TGF-b
participates in the control of cell proliferation,
differentiation, adhesion, and deposition of the
ECM (Figure 7). These cellular events are critical
in tissue growth, remodeling and repair. In the
earlier’ 90s, it was proposed that decorin and other
SLRPs may modulate the activity of this growth
factor (Yamaguchi et al., 1990). Overproduction of
TGF-b in response to injury and disease is thought
to be a major cause of tissue fibroses because it
stimulates deposition of ECM by the following
mechanism: up-regulating synthesis of matrix
components such as collagens, proteoglycans and
FN; up-regulation of the inhibitors of matrix-
degrading enzymes; and down-regulation of the
expression of these degradative enzymes (Border et
al., 1992; Isaka et al., 1996).
Figure 7. Regulation of decorin and its relationship to cell cycle
control. TNF-a and TGF-b both down-regulate decorin, but by
different mechanisms. Decorin core protein has a different effect
on cells, probably through phosphorylation of a receptor and
activation of the mitogen-activated protein (MAP) kinase
pathway, resul-ting in upregulation of p21. Outside the cell,
increased decorin production inhibits collagen fibrillogenesis,
resulting in thinner collagen fibrils.
Decorin, biglycan, and fibromodulin bind to
active TGF-b1, b2 and b3 via their core proteins,
with both high-affinity and low-affinity binding
sites (Hildebrand et al. , 1994). The
chondroitin/dermatan sulfate chains of decorin and
biglycan appear to somewhat hinder this binding,
making TGF-b binding to fibromodulin more
effective than binding to decorin or biglycan within
the tissue. This binding was specific for TGF-ß out of
several other growth factors tested and suggests an
important role for these small proteoglycans in
regulating TGF-b capacity to induce the synthesis of
matrix components. Studies by Markmann et al.,
(2000) suggest that decorin must be bound to a
matrix to sequester and inactivate TGF-b.
In turn, TGF-b contributes to the regulation of the
synthesis of the small proteogylicans. Several
investigators have reported that TGF-bs increase the
synthesis of small proteogylicans in cultures of
isolated chondrocytes. It has also been reported that
there is a decorin decrease in mRNA in chondrocytes
cultured with TGF-b in monolayers (Roughley et al.,
1994) and that TGF-b inhibited decorin synthesis in
chondrocyte monolayers, but not in chondrocytes in
alginate beads (Demoor-Fossard, 1998). There is no
information about the effect of TGF-b on
fibromodulin in chondrocytes, with the exception of
preliminary data showing two fold increases in
fibromodulin at the RNA and protein level in
chondrocytes cultured in alginate beads (Burton-
Wurster, 2003).
2.3.2. Hyalectans proteoglycans
A common feature of these proteoglycans is their
tridomain structure: an N-terminal domain that binds
to hyaluronan, a central domain that carries the
glycosaminoglycan side chains, and a C-terminal
region that binds to lectins. Alternate exon usage
occurs extensively, and various degrees of
glycanation and glycosylation make these
proteoglycans appropriate bridges between surfaces
and extracellular matrices. This family currently
contains four distinct genes: versican, aggrecan,
neurocan and brevican.
2.3.3. Basement membrane proteoglycans
Basement membranes are thin, cell-associated
sheets of multimodular molecules, most of which
interact with each other to form a barrier of charged
molecules, thereby acting as true biological filters.
Basement membranes are biochemically complex and
heterogeneous structures containing laminin, collagen
type IV, nidogen, and at least one type of
proteoglycan. Three proteoglycans are
characteristically present in vascular and epithelial
basement membranes of mammalian organisms:
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perlecan, agrin, and bamacan (Table 8). The first
two primarily carry heparan sulfate side chains,
whereas the latter primarily carries chondroitin
sulfate. The chimeric structural design of these
proteoglycans suggests that they may be involved
in numerous biological processes. It is unclear why
only these three seemingly diverse molecules are
associated with the basement membranes (Iozzo,
1998).
3. CELL ADHESION MOLECULES
The overall architecture of a tissue is
determined by adhesion mechanisms that involve
not only cell-cell interactions but also cell-matrix
interactions. The interface between cells and ECM
molecules is dependent upon cell adhesion molecules
(CAM). CAM are cell surface macromolecules that
dictate cell-to-cell and cell-to-ECM interactions,
thereby mediating the processes of adhesion,
migration, differentiation, and intracellular signaling
(Gumbiner, 1996). This basic function plays a critical
role in normal processes, such as embryonic
development and tissue morphogenesis, as well as in
pathological processes such as tumor cell invasion
and metastasis, thrombosis, and inflammation (Hynes
and Lander, 1992). These cellular interactions with
the ECM are highly regulated, in part, by a family of
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catabolic enzymes that selectively degrade ECM
proteins, referred to as matrix metalloproteinases
(MMPs) (Chen and Wang, 1999). Collectively,
these molecules and remodeling enzymes create an
envi ronment of chemoat t rac tant and
chemorepulsant cues. The proteinase activity
targets the extracellular domain of CAM, whereas
the intracellular domains interact with cyctoskeletal
components. The interactions of cells with
neighboring cells and the surrounding ECM are
mediated by different classes of cell-adhesion
receptors, including integrins, cadherins, and
members of the immunoglobulin and selectin
families (Figure 8). Integrins primarily mediate
interactions of cells with components of the ECM
(Hynes, 1999). Following adhesion and clustering,
integrins recruit different cytoskeletal and
cytoplasmic proteins, which anchor the newly
formed complexes to the actin cytoskeleton. This
ultimately leads to the local remodeling of the actin
cytoskeleton and the formation of specialized
adhesive structures, called focal adhesions. In
addition to forming a structural link between the
ECM and the actin cytoskeleton, focal adhesions
are also important sites of signal transduction.
3.1. Integrins
The integrin terminology was first applied in a
1987 review article (Hynes, 1987) to describe a
family of structurally, immunochemically, and
functionally related cell-surface receptors, which
i n t e g r a t e d the ECM with the intracellular
cytoskeleton to mediate cell migration and adhesion.
Integrins are a large family of heterodimeric cell-
surface receptors, composed of an a- and b-subunit,
which bind to a wide variety of ECM and cell-surface
ligands (Hynes, 1992). The three original b subunits
(b1, b2, and b3) identified have now expanded to
eight, and the number of a subunits stands at 18. In
the recent survey of the human genome, 24 a- and 9
b-subunits have been identified (Venter et al., 2001).
However, their existence is not yet firmly established.
The 18 a- and 8 b-subunits interact noncovalently in
a restricted manner to form 24 different heterodimers
(Plow et al., 2000, Hynes, 1992; Table 9). Each of the
24 integrins appears to have a specific, nonredundant
function. In part, this is evident from the details of
their ligand specificities but also is shown by the
phenotypes of knockout mice (Hynes, 2002).
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Integrins are Ca2+-dependent adhesive
molecules that form a large family of proteins
involved in cell-to-cell and cell-to-ECM contacts
(Jones, 1996; Hynes. 1992). Integrin receptors are
transmembrane proteins that are widely distributed
(Figure 8). The extracellular portion of integrins
interacts with ECM molecules such as fibronectin,
laminin, vitronectin, and tenascin (Plow et al.,
2000; Perris, 1997; Varnum-Finney et al., 1995), as
well as with various plasma proteins, cell-surface
proteins, and microbial pathogens (Sugimori et al.,
1997). The intracellular portion makes contact with
actin cytoskeleton via intermediate proteins such as
a-actinin, talin, tensin, and vinculin. Thus, the
binding of a specific ligand to a particular integrin
receptor permits a link between the ECM and the
actin cytoskeleton through these intermediate
proteins, that in turn, trigger intracellular signaling
pathways that mediate changes in cellular shape,
motility, growth, gene regulation, and apoptosis
(Miranti and Brugge, 2002; Frisch and Screaton,
2001; Giancotti and Rouslahti; 1999; Frisch and
Ruoslahti, 1997).
3.1.1. The integrin family
Different a and b subunits are expressed in
limited combinations (Rupp and Little, 2001) and
exhibit different ligand specificities (Table 9). The
integrins that a given cell expresses therefore
control the repertoire of ECM components with
which the cell can interact. Integrins bind to ligands
in a manner that is dependent upon both affinity
and avidity and is influenced by ligand
conformation and the capacity to anchor and array
(multimerize) within the pre-existing ECM. Thus,
different ligands, or different forms of a particular
ligand, can transmit distinct signals to a cell
through the same integrin (Geiger et al., 2001; Koo
et al., 2002; Stupack et al., 1999). Because ECM
components may be recognized by more than one
integrin, competitive or cooperative binding among
different integrin heterodimers adds an additional
layer of complexity to cellular responses to the ECM.
A further level of complexity is introduced by the
existence of alternative splicing.
3.1.2. The b integrin subunit
Each b integrin subunit consists of a large
extracellular domain that mediates cell-matrix and
cell-cell contacts, a transmembrane domain, and a
cytoplasmic domain associated with the cytoskeleton.
Integrins are capable of transducing information in a
bidirectional manner, and the b subunit is now
recognized as playing an important role in this
process (Green et al., 1998). Most b integrins have
relatively small cytoplasmic domains consisting of
fewer than 60 amino acids and do not contain
catalytic or consensus protein-protein-binding motifs
present in various b subunits. An exception is the
cytoplasmic domain of the b 4, which is
approximately 1,000 amino acids long and contains
two pairs of fibronectin type III repeats separated by
a connecting segment. The cytoplasmic domain of b5
is structurally and functionally unique with regard to
other integrin subunits (Table 10) and shares only
38% homology to the cytoplasmic domain of b1 or
b3 (Hemler et al., 1994).
It has been proposed that the structural
requirements for association with av prevented
further primary sequence divergence between b3 and
b5. Although both avb3 and avb5 integrins bind to
vitronectin, they probably mediate different
postligand-binding events. For instance, in the
absence of exogenous soluble factors, the integrin
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avb5 fails to promote cell adhesion, spreading and
migration. On the other hand, the avb3 integrin
can induce such events without additional
stimulation by cytokines (Klemke et al., 1994;
Lewis et al., 1996; Friedlander et al., 1995).
Although many integrins can bind FN (Table
9), the a5b1 integrin is the major FN receptor on
most cells. This integrin mediates such cellular
responses to FN substrates as adhesion, migration,
assembly of ECM, and signal transduction. Integrin
ligands, such as FN, are not passive adhesive
molecules but are active participants in the cell
adhesive process that leads to signal transduction.
Fibronectin is the best-characterized integrin ligand
is. The biological function of the central cell-
adhesive region of FN requires two critical amino
acid sequences -an Arg-Gly-Asp (RGD) sequence
and a Pro-His-Ser-Arg-Asn (PHSRN) sequence,
which function in synergy- for optimal binding to
the integrin. The b 1, b 3, and b 5 integrin
intracellular domains are sufficient to initiate
signal-transduction pathways. Furthermore,
alternative splicing can regulate the ability of b
integrin intracellular domains to participate in
signal transduction.
3.1.3. Integrin function
Integrins were initially shown to function only
as cell-matrix adhesion molecules (Tamkun et al.,
1986), but it has become well accepted that they are
important signal transducers (Giancotti and
Ruoslahti, 1999; Shattil and Ginsberg, 1997; Clark
and Brugge, 1995). Integrins can signal through the
cell membrane in either direction: the extracellular
binding activity of integrins is regulated from the
inside of the cell (inside-out signaling), whereas the
binding of the ECM elicits signals that are
transmitted into the cell (outside-in signaling)
(Clark and Brugge, 1995; Howe et al., 1998).
Integrins undergo dynamic changes during the
ligand binding process, including relative
movements of subunits and conformational changes
within domains (Humphries and Newman, 1998;
Loftus and Liddington, 1997). Because the
integrins themselves do not possess enzymatic
activity, to signal they must trigger downstream
molecules (Giancotti and Ruoslahti, 1999; Clark
and Brugge, 1995; Schoen-waelder and Burridge,
1999). Examples include activation of tyrosine
kinases such as pp125 focal adhesion kinase (FAK)
or small GTPases such as Rho or Rac and regulation
of cytoskeletal components such as talin, paxillin, or
p130CAS. Integrin b chains are sufficient to activate
downstream signaling molecules, such as FAK, and
can regulate cell-cycle progression and actin
cytoskeleton assembly. b tails are thus necessary and
sufficient to correct subcellular localization of
integrins and to activate signaling pathways, and
regulate the affinity of integrins for their ligands. The
b integrin cytoplasmic domain binds numerous
molecules, which are subunit specific. Thus, b1 A
binds to FAK, paxillin, a-actin, Talin, ICAP, myosin,
ILK, Grb2, Shc, melusin, and skelemin. The b2
subunit interacts with ILK and cytohesin-1.
Molecules that bind to b3 tail are: b3-endonexin,
ICAP, ILK, myosin and Shc (Liu et al., 2000). To
date, the theta-associated protein 20 (TAP 20) (Liu et
al., 2000) is the only molecule known to interact
exclusively with the b5 cytoplasmic domain.
ECM-integrin interactions function in a
bidirectional manner across cell membranes. In this
regard, they can influence a wide range of activities
including alterations in cell morphology, migration,
proliferation, differentiation, and survival; gene
expression; suppression of tumorigenicity; changes in
intracellular pH; or concentration of cytosolic Ca2+
(Figure 9).
Figure 9. Signal-transduction pathways emanating from integrins
(blue) regulate numerous cellular processes, including actin
organization (orange) and adhesion complex remodeling (green),
which together influence cell movement (red), as well as gene
expression and cell-cycle regulation (turquoise) and cell survival
(gray).
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In addition to their normal cellular function
integrins also play a role in the pathogenesis of
many major human disease such as: inflammation,
thrombosis, metastasis, osteoporosis and infection
(Green et al., 1998).
3.1.3.1. Integrins in migration
Cellular migration and invasion are governed
at both the extracellular and intracellular levels by
several factors, and depend on the cell's carefully
balanced dynamic interaction with the ECM.
During migration, cells are constantly making and
breaking contact; cells project lamellipodia (a broad
membrane projection at the leading edge of the cell
in the direction of movement) that attach to the
ECM, and simultaneously break existing ECM
contacts at their trailing edge. This allows the cell
to pull itself forward (Sheetz, 1999). Extension of
lamellipodia is induced by actin polymerization and
facilitated by a localized decrease in membrane
tension (Raucher and Sheetz, 2002). Retraction of
the cell edge is dependent on the adhesive
environment and occurs either by fracturing the
cell-ECM linkage in highly adhesive environments
(during slow migration) or by simple dissociation
of integrins in less adhesive environments (during
fast migration) (Palecek et al., 1998; Palecek et al.,
1999). During invasion, cells release proteases that
degrade and remodel the ECM, promoting cell
passage through the stroma and entrance into new
tissue. This proteolytic process must be tightly
controlled, such that the ECM is sufficiently
degraded to facilitate cell passage, but not so
degraded that cellular traction is lost.
3.1.3.2. Integrins in cell adhesion
Cell adhesion is one of the defining features of
multicellular organisms and underlies the
organization of cells into discrete tissues and organs
during metazoan development. Adherent cells in
culture form specialized structures, termed focal
adhesions or focal contacts, at sites of close contact
between the plasma membrane and the underlying
ECM at which integrins, signaling and cytoskeletal
molecules are localized. Adhesion to ECM
molecules through integrin heterodimers is a
fundamental requirement for cells to acquire the
traction necessary for movement. Integrins mediate
stable adhesion of cells to their substrate by
providing a physical link between the ECM and the
cytoskeleton (Hynes, 1992). Interestingly, the
maximum rate of cell migration occurs at
intermediate levels of adhesiveness (Duband et al.,
1991; Palecek et al., 1997). At low levels of
adhesiveness, weakly attached cells cannot generate
sufficient traction to move efficiently. At high levels
of adhesiveness, cells cannot break contact and are
therefore immobile. Intermediate levels of adhesion
allow traction at the cell front while releasing
contacts at the rear, resulting in net forward
movement. Integrins not only send signals to the cell
in response to the extracellular environment, but they
also respond to intracellular cues and alter the way
they interact with the extracellular environment
(Brown and Hogg, 1996). “Inside-out” signaling
regulates integrin adhesiveness by modulating the
affinity and avidity of integrins for their ECM
ligands, regulating cell invasion and migration.
Integrin-mediated adhesion and signaling
regulate a variety of cell functions, including
leukocyte homing and activation, bone resorption,
clot retraction, cell response to mechanical stress,
programmed cell death, tumor cell growth and
metastases (Clark and Brugge, 1995). Integrin (a and
b) adhesiveness to ECM components is regulated by
altering the integrin's affinity for its ECM ligands
and/or by altering the integrin's avidity. Small GTP-
binding proteins seem to have a prevalent role in
these processes. The activation of the small GTP-
binding protein R-RAS can lead to increases in
integrin affinity for the ECM, whereas H-RAS
activation can lead to decreases in integrin affinity
(no ECM binding). Similarly, activation of the small
GTP-binding proteins RAC and CDC42, and protein
kinase C (PKC), can lead to clustering of integrins,
thereby increasing integrin avidity. The careful
regulation of each of these events is necessary for
efficient cell migration.
3.1.3.3. Integrins in intracellular signaling
Integrins are essential for cell migration and
invasion, not only because they directly mediate
adhesion to the ECM, but also because they regulate
intracellular signaling pathways that control
cytoskeletal organization, and force generation and
survival. During migration, cells are constantly
making and breaking integrin contacts. Depending on
the composition of the ECM, integrins activate one or
more intracellular signaling pathways. These
pathways typically involve phosphorylation of FAK,
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recruitment of adaptor proteins, activation of small
GTPases and subsequent activation of downstream
effector molecules (Figure 10).
Integrin ligation induces a complex network of
signaling pathways to control cell migration.
Integrin (a and b) binding to ligands in the ECM
activates FAK, which binds and activates multiple
signaling proteins. FAK autophosphorylation at
tyrosine 925 causes it to bind growth-factor-
receptor-bound protein 2 (Grb2) (Schlaepfer et al.,
1994) and activate another small G protein, Ras.
FAK activation also promotes Src-dependent
phosphorylation of shc (Schlaepfer and Hunter,
1997), leading to Grb2 recruitment and Ras
activation.
Figure 10. Regulation of intracellular signaling by integrins
Activated Ras recruits Raf to the cytoplasmic
membrane, where it can be activated by protein
kinases such as Src (Fabian et al., 1993), thereby
leading to mitogen-activated protein kinase kinase
(MEK) and extracellular-signal-regulated kinase
(ERK) activation. Once activated by FAK or shc,
Ras can activate phosphatidylinositol 3-kinase
(PI3K) and RAF. Activated Src can also
phosphorylate CRK-associated substrate (CAS),
enabling it to bind CRK, dedicator of cytokinesis 180
(DOCK-180), leading to Rac activation. Activated
Rac, in conjunction with activated Cdc42, can
regulate numerous biochemical pathways, including
activation of p21-activated kinase (PAK). PAK
affects numerous pathways and also activates Raf's
kinase activity. MEK, once activated by Ras and Raf,
can phosphorylate and activate ERK. ERK activation
leads to transcriptional activity, alterations in integrin
affinity for ligand, and myosin-light-chain kinase
(MLCK) activity. Independent of FAK activation,
signaling molecules such as SHC and PKC are also
activated by integrin adhesion events. Activating
these molecules can also eventually lead to Ras and
Raf activation, along with the alterations in the
cytoskeleton that are necessary for the migratory
phenotype.
These signals, in concert with signals derived
from growth factors, regulate cell behavior in a
complex tissue microenvironment.
3.1.3.4. Integrins in apoptosis
Finally, we must consider the potential role of
integrins as regulators of apoptosis; there are several
very distinct versions of this class of models. In the
classical view (Fig. 11a), for which there is a great
deal of evidence, integrin ligation provides a survival
signal (through the PI3 kinase–Akt pathway), and
cells are dependent for survival on anchorage
(Meredithet et al., 1993). In this view, when cells lose
their integrin-mediated adhesion they undergo
apoptosis, called anoikis (Frisch and Screaton, 2001)
Indeed, in the early experiments that showed LM609
or RGD-based peptides as inhibiting angiogenesis,
they induced apoptosis of ECs and this was
interpreted as anoikis (Brooks et al., 1994).
Later work showed that RGD-based peptides
could induce apoptosis by directly activating
caspases, without any involvement (positive or
negative) of integrins (Figure 11b) (Buckley et al.,
1999; Adderley and Fitzgerald, 2000). Lately, a third
model has been described suggesting that unligated
integrins promote apoptosis by directly recruiting
caspase-8 (Stupack et al., 2001) (Figure 11c) named
"integrin-mediated death". These investigators
suggest that when inhibitors block avb3, unoccupied
avb3 triggers apoptosis of endothelial cells (Stupack
et al., 2001; Cheresh and Stupack, 2002).
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Figure 11. Three models for endothelial apoptosis. a , The
classical model, in which integrin engagement by ligand is
necessary to provide survival signals. Inhibitors block ligand
binding and thus the survival signal. b, The caspase activation
model, in which RGD peptides directly activate caspases and
trigger apoptosis without any involvement of integrins. c, The
unligation model, or “integrin-mediated cell death”, in which
unligated integrins directly bind and activate caspase-8.
3.2. Cadherins
Cadherins are a family of transmembrane
glyco-proteins that mediate calcium-dependent cell-
cell adhesion. The adhesion properties (the
hemophilic nature activity, the high specificity of
the interaction and the tissue specificity of the
expression) reveal that various cadherins are
involved in the mediation of specific cell-cell
adhesion and play a pivotal role in the formation
and maintenance of tissues (Suzuki, 1996; Chothia
and Jones, 1997). Many cadherins and cadherins-
related proteins have been identified in various
tissues of different organisms; they are also
involved in embryonic morphogenesis and the
formation of stable connections among cells in
solid tissues and epithelial cell layer (Suzuki, 1996;
Chothia and Jones, 1997). Members of the cadherin
family can be divided into four subgroups: classic
cadherins, desmosomal cadherins, protocadherins,
and atypical cadherins. Many tissue-specific
cadherins have been identified: these include
epithelial (E)-cadherin, neuronal (N)-cadherin,
placental (P)-cadherin, vascular endothelial (VE)-
cadherin and others (Vleminckx and Kemler,
1999). Proteins are designated as members of the
broadly defined cadherins family if they have one
or more cadherin repeats, each one consisting of
approximately 110 amino acids and containing
amino-acid motifs with the conserved sequences
LDRE, DXNDN, and DXD (Oda et al., 1994).
Regulation of cell–cell adhesion by VE-cadherins is
critical during angiogenesis. For example, VE-
cadherins mediate endothelial barrier function, and
angiogenesis and can also support cross-talk with
VEGF receptors (Corada et al., 2001; Liao et al.,
2000).
Cadherins serve as homophilic-adhesive
molecules revealing a cell-adhesion preference for
other cells that express the identical cadherin family
member. This feature serves to segregate cells into
distinct tissues during development (Takeichi, 1991;
Takeichi, 1995). Each form of cadherin shares the
characteristic of five homologous extracellular
domains (Figure 8), a single membrane-spanning
segment, and a cytoplasmic unit attached via catenins
to cytoskeletal actin microfilaments (Gumbiner and
McCrea, 1993; Yap et al., 1997). The specificity of
these homophilic interactions appears to be mediated
by the first extracellular domain, at least in the case
of E- and P-cadherin. N- and R- (retinal) cadherin
can also execute heterophilic interactions, although
homophilic is preferred. N- and R-cadherin possess a
nearly identical amino-acid sequence in the region
implicated in homophilic-binding specificity. This
observation suggests that the first extracellular
domain contains the binding site necessary for
“specific homophilic adhesion” (Wright et al., 2002).
The intracellular portion of the cadherin
molecules interacts with cytoskeletal proteins and
signal-transduction pathways primarily via a- and b-
catenin (Mao et al., 2001; Kintner, 1982; Nagafuchi
and Takeichi, 1988). Many studies have confirmed
the importance of the cytoplasmic tail, and in
particular, the catenin-binding site, for adhesion.
Removal of this binding site prevents cadherin-
mediated adhesion in cultured cells (Ozawa et al.,
1990). Thus, this pathway appears to have a profound
influence on the regulation of cell adhesion.
3.3. Immunoglobulin superfamily adhesive
molecules
The immunoglobulin (Ig) super family of CAMs
is Ca2+-independent cell-adhesion molecules and
comprise a large variety of glycoproteins mostly
expressed at the cell surface. Typically, Ig CAMs
have a large amino-terminal extracellular domain
containing the Ig folds, a single transmembrane
helical segment, and a cytoplasmic tail (Aplin et al.,
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1998). The extracellular domain of these molecules
is made up of a number of Ig motifs and FN-III
repetitions (Gennarini et al., 1989). Thus, the
members of this category differ with respect to the
number of Ig and FN repeats in their structures
(Figure 8). Many of these molecules evidence
several isoforms with specific functions and
patterns of expression. The characteristics of
attachment to the cell membrane, and the length of
the intracellular domain, largely determine the
functional consequences of each member of this
subfamily. Molecules carrying Ig-like domains are
endowed with different functions, including
cytoskeletal organization, endocytosis, adhesion,
migration, growth control, immune recognition,
viral receptors, inflammatory reactions, and tumor
progression. Several members of the Ig
superfamily, namely, ICAMs, VCAM-1,
MadCAM-1, PECAM-1 and CD2, are found to
mediate the adhesion events of the immune system.
One of the most important contexts for Ig
CAMs is the developing nervous system, where
many different members of this superfamily are
involved in axon guidance and in the establishment
and maintenance of neural connections (Murase
and Schuman, 1999). The classic example of a
neural Ig superfamily adhesion receptor is NCAM,
which contains five Ig folds in its extracellular
portion (Crossin and Krushel, 2000). NCAM
functions as a homotypic, calcium-independent
cell-cell adhesion receptor; however, the precise
mechanism of NCAM-mediated cell-cell
interaction remains controversial. Another group of
Ig CAMs important in neural development are the
netrin receptors, such as deleted in colon carcinoma
(DCC), that interact with laminin-like netrins in the
ECM and provide specific guidance cues to
migrating axons (Culotti and Mer, 1998). Yet
another group of key Ig CAM receptors involved in
neural development is the dozen or so members of
the Eph subfamily of transmembrane tyrosine
kinases that bind their cognate ligands (ephrins) on
neighboring cells (Bruckner and Klein, 1998).
Thus, Ig CAMs can be involved in either
homotypic (NCAM) or heterotypic (DCC, Eph
kinases) adhesive interactions.
3.4. Selectins
The selectins were cloned in 1989 and
represent a new family of CAMs primarily involved
in the regulation of leukocytes (Kansas, 1996). They
are a group of type I transmembrane glycoproteins
with an extracellular region consisting of an amino-
terminal lectin domain configured to bind
carbohydrate ligands. They also possess a single
growth-factor-like domain, two to nine short
consensuses repeat domains, and a single membrane-
spanning region with a cytoplasmic tail. Selectin
molecules appear to regulate early leukocyte-EC
interactions, especially the tethering and rolling of
leukocytes along the venular wall (Lee et al., 1995).
At present, this family consists of three molecules: 1)
L-selectin which is expressed on nearly all blood
neutrophils and monocytes, on some natural killer
cells, and on many blood-borne T and B cells; 2) E-
selectin expression is limited to endothelium,
especially endothelium responding to inflammatory
stimuli such as IL-1, TNF-a, and bacterial lipopol-
ysaccharide (Bevilacqua et al., 1989; Springer, 1995;
Hartwell and Wagner, 1999); 3) P-selectin is
expressed on both endothelium and platelets but in a
stored preformed state in secretory storage granules
located within a-granules and Weibel-Palade bodies
(McEver et al., 1989). P-selectin is quickly expressed
at the cell surface upon fusion, initiated by agonists
including thrombin, histamine, and activators of
PKC. In addition to this fusion-initiated expression of
P-selectin at the cell surface, P-selectin expression on
endothelium is also transcriptionally regulated (Yang
et al., 1999; Gotsch et al., 1994; Sanders et al., 1992).
P-selectin gene transcription can be induced by IL-1,
TNF-, or bacterial L-polysaccharide with a latency of
2-4 hours. Thus, P-selectin can be expressed during
both the early and late stages of an inflammatory
response (Kansas, 1996). Although all three selectins
are involved in the mediation of rolling of leukocytes
along the vessel wall near the point of injury,
different selectins appear to be active at different
times during an inflammatory response.
4. LIFE AND DEATH OF CELLS
Proper balance of cell survival and cell death in
the organism is essential for physiological processes
that play a critical role in controlling the number of
cells in development, and functioning of the immune
system, and throughout an organism's life by
removing cells at the appropriate time. One feature of
the immune system is the production of a large
amount of cells. As approximately 1011 to 1012 cells
are produced every day in healthy adult humans, this
rapid proliferation needs to be balanced by apoptosis
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to maintain a constant cell number. Changing this
balance in either direction has pathological
consequences. An abnormally high rate of cell
death is found in neurodegenerative diseases,
including Alzheimer's and Parkinson's diseases,
AIDS and cardiovascular diseases; whereas delayed
cell death contributes to a wide variety of human
cancers (Thompson, 1995). Numerous cell-death
mechanisms are tissue specific and cell type
specific. These are regulated by a large number of
extracellular and intracellular signals governed by
the environment of the cell. The crucial role of cell
death in many diseases has spurred intense research
to understand the regulation of apoptotic pathways.
The life-and-death decision at the cellular level
is controlled by environmental cues, including
death-receptor (DR) ligands (Ashkenazi and Dixit,
1999) and growth factors (Dvorak et al., 1995;
Eliceiri, 2001), as well as physical stimuli such as
mechanical stress (Ingber, 1992), or radiation
(Wahl and Carr, 2001). This decision is profoundly
influenced by the components of the ECM, which
can change dynamically during differentiation,
development and other tissue-remodeling events
(Figure 12). Cell-adhesion receptors and new ECM
proteins, deposited from intracellular stores or
synthesized de novo (Brown et al., 1993; Petersen
et al., 1998), interact with both pre-existing and
proteolytically exposed sites in the assembled ECM
(Davis, 1992; Xu et al., 2001).
The ongoing remodeling presents a constantly
changing environment, contrasting with the static
ECM in “resting” tissues, and presents new
information to cells that governs their behavior. The
principal adhesion receptors that convey this
information are the integrins. In addition, complex
regulatory systems are required to form and maintain
the array of tissue architectures present in
multicellular organisms. Among these, programmed
cell death is crucial for developmental and
physiological processes, including morphogenesis,
wound repair and tissue differentiation.
Inappropriately triggered cell death can alter tissue
structure or function, compromising embryonic
viability (Ranger et al., 2001). Conversely, the failure
of cells to undergo apoptosis can result in a range of
effects from embryonic death to neoplasia (Lee and
Bernstein, 1995; Ranger et al., 2001; Reed, 1999) or
autoimmune disease (Eguchi, 2001; Moulian and
Berrih-Aknin, 1998).
4.1. Apoptosis
Apoptosis was first described by Kerr et al.
(1972), and is defined by the morphological
appearance of the dying cell, which includes
membrane blebbing, chromatin condensation, nuclear
fragmentation, loss of adhesion and rounding (in
adherent cells), and cell shrinkage. Biochemical
features associated with apoptosis include
internucleosomal cleavage of DNA, leading to an
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oligonucleosomal "ladder" (Cohen et al., 1994);
phosphatidylserine externalization (Martin et al.,
1995b); and proteolytic cleavage of a number of
intracellular substrates (Martin & Green, 1995).
The appearance of phosphatidylserine on the
outside of the plasma membrane was assumed to
indicate commitment to cell death. It may facilitate
recognition by phagocytes, subsequent
phagocytosis and degradation of the apoptotic cell.
This can be visualized by the binding of
fluorescein-labeled annexin V. As a result of the
plasma membrane changes, apoptotic cells are
rapidly phagocytosed prior to the release of
intracellular contents and without induction of an
inflammatory response. This is not to be confused
with necrosis, where acute environmental changes
induce cell swelling and lysis, which are followed
by an acute inflammatory response.
Mechanisms that transfer the death signal to the
cell’s apoptotic machinery fall into two broad
categories: 1) the ligation of a death-receptor leads
to the recruitment of the adapter protein FADD and
procaspase-8, which becomes cleaved and activated
at the receptor complex, initiating caspase cascade
(Figure 13 Left), and 2) the mitochondria/apop-
tosome pathway (Figure 13 right) is triggered by a
number of apoptotic stimuli. The intracellular
protein interactions triggered by the death-inducing
receptors can be attributed to two structural motifs
within the proteins concerned. Both motifs are able
to associate with homologous regions in other
proteins, and thus prompt binding of such proteins
to one another (Wallach, 1997). One motif, the
“death domain” (DD), is found in several death-
inducing receptors of the TNF family, including
CD95 (also called Fas or Apo-1), CD120a (the p55
TNF receptor) and others. It also occurs in several
cytoplasmic adaptor proteins that bind through this
domain both to receptors and to each other (as, for
example, in the MORT-1/FADD and TRADD
adaptors). The other motif, the “death effector
domain” (DED), is found in MORT-1/FADD
upstream of the DD; it also occurs in duplicate in
two caspases, caspase 8 (MACH/ FLICE/Mch-5)
and caspase 10 (Mch-4/ FLICE-2). Binding of these
two caspases to MORT-1/FADD through
association of their DED motifs, and consequent
activation of the caspases by their proteolytic
cleavage (apparently by self-processing), are
thought to be critical steps in the initiation of the
killing process. The caspases are believed to cause
apoptotic phenotype by cleaving or degrading several
important substrates, which ultimately results in cell
death. An early, not well understood, step is the
mitochondrial release of apoptosis-inducing
molecules -including cytochrome c, apoptosis-
inducing factor (AIF), HtrA2 and Smac/DIABLO-
into the cytosol. Initially, cytochrome c, together with
dATP, associates with Apaf1. This event unmasks the
caspase-recruitment domain (CARD) motif in Apaf1
and allows binding and activation of procaspase-9.
Once activated, caspase-9 propagates the apoptotic
signal. Positive feedback loops involving Bid,
mitochondria, apoptosome, caspase-9, effector
caspases and caspase 8 are able to amplify the death
signal. The apoptosome pathway is further
potentiated by AIF, through augmentation of
mitochondrial release of cytochrome c and
procaspase-9. Negative modulators of apoptosis such
as FLIPs and inhibitors of apoptosis (IAPs) may
negatively influence the transmission of the apoptotic
signal. Smac/DIABLO and HtrA2 may abolish
apoptosis inhibitory action of IAPs.
Figure 13. Apoptotic signaling pathways. Cellular stress induces
proapoptotic Bcl-2 family members to translocate from the cytosol
to the mitochondria, where they induce the release of cytochrome
c. Cytochrome c catalyzes the oligomerization of Apaf-1, which
recruits and promotes the activation of procaspase-9. This, in turn,
activates procaspase-3, leading to apoptosis. Alternatively, the
activation of caspase-8 by ligation of the death receptor Fas is
illustrated. Ligated Fas recruits FADD to the intracellular region,
which in turn recruits procaspase-8. The procaspase-8
transactivates, and the mature caspase now can cleave and activate
procaspase-3, leading to apoptosis. Signaling from the Fas receptor
to mitochondria involves cleavage of the BH3-only protein, Bid,
by caspase-8. Bid subsequently induces cytochrome c release and
downstream apoptotic events.
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4.1.1. The apoptosis executioners: caspases
The initiation of programmed cell death can
occur in a variety of ways, and the appearance of
common morphological effects in cells indicates
the presence of common machinery (Green and
Evan, 2002; Leblanc, 2003). Caspase activation is
central to many, if not all, of the apoptotic
pathways. Their ability to proteolytically cleave
selected cellular proteins, assures the progress and
irreversibility of apoptosis (Slee et al., 1999). Thus
far, the caspase gene family contains 14
mammalian members, of which, 11 human
enzymes are known. Caspases share similarities in
amino-acid sequence, structure, and substrate
specificity (Nicho-lson and Thornberry, 1997).
They are expressed as proenzymes (zymogens) that
contain three domains: an N-terminal prodomain, a
large subunit containing the active-site cysteine
within a conserved QACXG motif, and a C-
terminal small subunit. Caspases are among the
most specific proteases, with an unusual and
absolute requirement for cleavage after aspartic
acid (Asp) residues (Stennicke and Salvesen, 1998).
An aspartate cleavage site separates the prodomain
from the large subunit, and an interdomain linker
containing one or two aspartate cleavage sites
separates the large and small subunits. The
presence of Asp at the maturation cleavage sites is
consistent with the ability of caspases to auto-
activate or to be activated by other caspases as part
of an amplification cascade.
4.1.2. Caspase substrates during apoptosis
The most prevalent caspase in the cell is
caspase-3. It is the one ultimately responsible for
the majority of the apoptotic effects, although it is
supported by two others, caspase-6 and -7.
Together, these three executioner caspases
presumably cause the apoptotic phenotype by
cleavage or degradation of several important
substrates. For example, high- and low-molecular
weight DNA fragmentation is caused by the action
of caspase-3 on a complex of caspase-activated
DNase (CAD)/DNA fragmentation factor (DFF)
40, a nuclease, and iCAD/DFF45, its inhibitor
(Enari et al., 1998; Liu et al., 1997). In non-
apoptotic cells, CAD is present as an inactive
complex with iCAD. During apoptosis, caspase-3
cleaves the inhibitor, allowing the nuclease to cut
the chromatin. Blebbing is orchestrated via the
cleavage and activation of gelsolin (Kothakota et al.,
1997), p21-activated kinase-2 (Lee et al., 1997;
Rudel and Bokoch, 1997), and most likely through
cleavage of fodrin (Martin et al., 1995) to dissociate
the plasma membrane from the cytoskeleton.
Cleavage of intermediate filaments contributes to
disorganize the cytoskeleton (Caulin et al., 1997).
The externalization of phosphatydilserine during
apoptosis is generally caspase-dependent (Martin et
al., 1996), although in some cell types, PS
externalization appears to be caspase independent
(Vanags et al., 1996).
4.1.3. Inhibitors of caspases
The deadly effects of caspase activation can be
counteracted in the cell by the presence of caspase
inhibitors. A number of proteins that can prevent cell
death through caspase activation have been
identified, of these, the most well known comprise a
family of inhibitors of apoptosis proteins (IAPs)
(Salvesen and Duckett, 2002). These were first
identified in baculovirus, but subsequently were
found in human cells. At least five different
mammalian IAPs -X-linked inhibitor of apoptosis
(XIAP, hILP), c-IAP1 (HIAP2), c-IAP2 (HIAP1),
neuronal IAP, and survivin- exhibit anti-apoptotic
activity in cell culture (Roy et al., 1997; Deveraux
and Reed, 1999; Deveraux et al., 1998; Liston et al.,
1996; Uren et al., 1996; Tamm et al., 1998; and
Ambrosini et al., 1997). The spectrum of apoptotic
stimuli that is blocked by mammalian IAPs is broad
and includes ligands and transducers of the TNF
family of receptors, pro-apoptotic members of the
ced-9/Bcl-2 family, cytochrome c, and
chemotherapeutic agents (LaCasse et al., 1998;
Deveraux and Reed, 1999). XIAP appears to have the
broadest and strongest antiapoptotic activity. XIAP,
c-IAP1, and c-IAP2 are direct caspase inhibitors
(Deveraux et al., 1997; Deveraux et al., 1999; Roy; et
al., 1997). They all bind to and inhibit active caspase-
3 and -7, and also procaspase-9, but not caspase-1, -6,
-8, or -10. The binding and inhibition of caspases by
IAPs is mediated by the so-called baculovirus IAP
repeats (BIR) domain(s) present within the IAP. BIR
is a conserved sequence motif of ~70 amino acids
that is repeated tandemly in a class of baculovirus
proteins (e.g., Op-IAP). All mammalian IAPs have
three BIR domains, except survivin, which has only a
single BIR. Interestingly, in the case of XIAP, a 136
amino-acid region spanning the middle BIR core was
found to be necessary and sufficient for inhibition of
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caspase activity (Takahashi et al., 1998). Another
region within the IAP, the RING domain, acts as an
ubiquitin ligase, promoting the degradation of the
IAP itself (Yang et al., 2000) and, presumably, any
caspase bound to it. Near the RING finger of both
c-IAP1 and c-IAP2 is a CARD domain, suggesting
that these IAPs might directly or indirectly regulate
the processing of caspases via CARD domain
interactions. In this fashion, IAPs put the brakes on
the apoptotic process by binding, inhibiting, and
perhaps degrading caspases.
4.2. Macrophages in cell survival and
apoptosis
Macrophages play an important role in the
immune system. They act by means of a number of
mechanisms: (a) directly, by destroying bacteria,
parasites, viruses and tumor cells; (b) indirectly, by
releasing mediators IL-1, TNF-a, etc. which can
activate other cells; (c) as accessory cells, by
processing antigen and presenting digested peptides
to T lymphocytes; and (d) by repairing tissue
damage.
Macrophages originate in the bone marrow and
migrate to body tissues through blood circulation,
and share a common precursor with neutrophils: the
GM-CFU. Through the expression of a series of
transcription factors, in which PU.1 plays a crucial
role, a differentiation process takes place where the
M-CSF receptors are expressed, a feature that
characterizes macrophages (Klemsz et al., 1990;
Valledor et al., 1998; Lloberas et al., 1999).
The bone marrow produces approximately
5x109 macrophages per day, which are released to
the circulating blood and exhibit a half-life of 18
hours (Van Furth, 1992). Most of the macrophages
that arrive to the tissues disappear, and the few that
prevail can exhibit a very long half-life, up to years.
In the absence of cytokines or growth factors, most
macrophages die by apoptosis (Figure 14). In
tissues, a small number of macrophages
differentiate under the influence of cytokines and,
depending on the tissue type, they may become
osteoclasts (bone), Kupffer cells (liver), microglia
(brain), etc. Macrophages proliferate in the
presence of growth factors, such as GM-CSF, M-
CSF or IL-3. Macrophages are critically important
in inflammatory reactions and, more specifically, in
hypersensitivity reactions. When macrophages are
needed at the inflammatory loci, in order to become
activated and fully functional, these cells need to
interact with IFN-g, a cytokine released by activated
T lymphocytes (Celada and Nathan, 1994) that acts
through interaction with the specific receptor (Celada
and Schreiber, 1987; Celada et al., 1989; Celada and
Maki, 1991). Murine models with an IFN-g gene that
has been inactivated by homologous recombination
have shown that this cytokine is necessary for the
development of hypersensitivity reactions and the
formation of granuloma in response to intracellular
microorganisms. Lipopolysaccharide (LPS), a
component of the cell membrane of gram-negative
bacteria, could induce some macrophage activities.
Figure 14. Production versus elimination of macrophages
4.3. Endothelial cells in cell survival and
apoptosis
A number of studies have shown that ECs can
undergo apoptosis in response to a variety of stimuli,
including serum growth-factor withdrawal, Fas
activation, and radiation injury (Gratton et al., 2001;
Nofer et al., 2001; Suhara et al., 2001). During both
normal development and pathology, the formation of
new vessels and the regression of pre-existing ones
are dependent on the balance between EC
proliferation and apoptosis. In mature vessels, EC
turnover is also under the control of these tightly
regulated phenomena. Since the vascular
endothelium is involved in various physiological
processes, EC apoptosis (and dysfunction) may
constitute an initial step in a variety of pathological
situations such as atherosclerosis and hypertension
(Nofer et al., 2001). Shed apoptotic membrane
particles that are highly procoagulant are found in the
blood of patients with acute coronary events (Nofer
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et al., 2001; Suhara et al., 2001). As for other cell
types, it has been hypothesized that interactions of
ECs with their microenvironment may be critical
for their survival.
Angiogenesis is strongly dependent on the
suppression of EC apoptosis. Many of the
proangiogenic growth factors promote the survival
of ECs. Both angiogenesis and EC survival also are
dependent on the attachment of ECs to the ECM
and to cell-cell contacts. Inhibition of growth-factor
signaling or adhesion-dependent signaling can
induce apoptosis directly and concomitant
angiogenesis inhibition. Moreover, a common
property of many angiogenic inhibitors is the
induction of EC apoptosis. Therefore, the events
that induce survival or apoptosis of ECs affect
angiogenesis. It is conceivable that ECs integrate
exogenous angiogenic and antiangiogenic stimuli
and transform them intracellularly into conflicting
survival and apoptotic signals. The prevailing
signals may determine the fate of the ECs and,
subsequently, the fate of the growing vessel.
Elucidation of the molecular mechanisms that are
involved in EC apoptosis and survival may lead to
the development of new therapeutic approaches to
enhance angiogenesis in the case of tissue ischemia
(e.g., revascularization of ischemic tissue) or to
inhibi t angiogenesis in the case of
neovascularization-dependent disease (e.g., tumor,
diabetic retinopathy).
4.4. Cell matrix regulation of endothelial cell
survival
Cell-to-cell and cell-to-matrix contacts are
necessary for the maintenance of survival of
anchorage-dependent cells such as ECs (Brooks et
al., 1994; Levkau et al., 1998; Meredith et al., 1993;
Re et al., 1994; Scatena et al., 1998). Loss of cell-to-
cell contact leads to the activation of a default death
programmed in a variety of cell types.
For instance, deficiency or truncation of VE-cadherin
mediates adhesion between ECs (Hermiston and
Gordon, 1995), which induces endothelial cell
apoptosis and abolishes transmission of the
endothelial survival signal by VEGF-A to Akt kinase
and Bcl2 (Carmeliet et al., 1999). ECs can also enter
into apoptosis after growth-factor deprivation and
this correlates with cleavage and disassembly of
intracellular and extracellular components of
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adherens junctions. Caspase-3 appears to initiate
proteolytic processing, leading to the cleavage of
FAK (Levkau et al., 1998), ß-catenin and
plakoglobin and to the shedding of VE-cadherin
(Herren et al., 1998), actively interrupting
extracellular signals required for EC survival. On
the other hand, platelet-endothelial cell-adhesion
molecule-1 (PECAM-1) homophilic adhesion
rescues ECs from serum deprivation-induced
apoptosis, whereas it has no effect on EC migration
and proliferation (Bird et al., 1999).
The importance of the interaction of EC with
ECM is highlighted by the fact that in absence of
any ECM interactions, ECs rapidly undergo
apoptosis (Meredith et al., 1993; Frisch and
Francis, 1994; Frisch, 2001). Integrins mediate the
adhesion of ECs to the ECM proteins (Stromblad
and Cheresh, 1996), and this interaction also
provides a potent survival signal that is important
for angiogenesis (Figure 15). There is also crosstalk
between integrin- and growth factor-mediated
signaling, which may act synergistically to promote
survival.
Various signaling cascades have been
considered to mediate the antiapoptotic effect of
integrins (Fig L&D-6). The ECM may generate
survival signals aiming at the suppression of a p53-
regulated cell death pathway. Survival signals from
fibronectin are transduced by the FAK,
phosphorylation of which leads to p53 inactivation
and maintenance of cell survival (Ilic et al., 1998).
Interaction with ECM proteins via the integrin
avb3 inhibits p53 activity, decreases the expression
of p21Waf1 and Bax (Stromblad et al., 1996), and
activates NF-kB (Scatena et al., 1998), therefore
promoting cell survival. This is particularly
important during migration of ECs in angiogenesis
as well as in the maintenance of tumor vasculature
(Rüegg et al., 1998).
However, integrins also transmit signals
directly through ligation-dependent recruitment of
nonreceptor tyrosine kinases from the FAK and Src
families, leading to the activation of several major
cell-signaling pathways. The consequent
downstream signals, especially via the mitogen-
activated protein kinase (MAPK) and
phosphatidylinositol 3-kinase (PI3K) pathways, are
critical for regulation of the cyclin-dependent
kinases (cdk) and cell-cycle progression (Schwartz
and Assoian, 2001). Since disruption of CDK
signaling can result in cell-cycle arrest, leading to
apoptosis, and integrin-sustained cell-cycle signaling
presents a basic mechanism by which integrins
promote cell survival. At the same time as inducing
antiapoptotic proteins, integrin-mediated signals
block the induction of death by proapoptotic Bcl-2
proteins. In addition to triggering the PI 3-kinase/Akt
pathway, integrin-mediated Ras activation also
results in the activation of the Raf/Mek/ERK pathway
(Giancotti and Ruoslahti, 1999; Schlaepfer et al.,
1999).
Figure 16. Antiapoptotic signaling pathways activated by
integrins. Binding of integrins to ECM promotes EC survival by
regulation of the expression of apoptosis-related proteins and
activation of protein kinase cascades and of growth-factor
receptors (Chavakis E and Dimmeler S, 2002).
The ECM may also generate survival signals
aiming at the upregulation of an anti-apoptotic
pathway mainly by promoting the anti-apoptotic
activity of the Bcl-2 family of proteins. Exposure
of human ECs to TNF-a and IFN-g results in
suppression of EC avb3 activity, leading to a
decreased avb3-dependent EC adhesion and survival.
In vivo, TNF-a and IFN-g interact with avb3 to
cause selective disruption of the tumor vasculature in
patients with melanoma (Rüegg et al., 1998).
Stimulation of human ECs with TNF-a leads to a
specific degradation of Bcl-2, a process that is
inhibited by specific proteasome inhibitors.
Evidence demonstrates that simple expression of
unligated integrin is sufficient to initiate cell death
among adherent cells. This "integrin-mediated death"
(IMD) was similarly induced by the cytoplasmic
domain of b1 or b3 integrins, but not b5, resulting in
the recruitment of caspase-8 to the cell membrane
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and its subsequent activation (Stupack et al., 2001).
These results reveal an unexpected role for
integrins as proactive mediators of cell death, and
document a novel mechanism for the induction of
apoptosis during tissue remodeling and
homeostasis. These findings may explain previous
observations in vivo, where angiogenesis was
suppressed in tissues treated with avb3 integrin
antagonists due to an induction of apoptosis of
angiogenic ECs (Brooks et al., 1994b; Stromblad et
al., 1996; Storgard et al., 1999).
Finally, angiostatin-induced EC apoptosis
(Clae-sson-Welsh et al., 1998; Lucas et al., 1998)
parado-xically involves FAK activation (Claesson-
Welsh et al., 1998). FAK activation by angiostatin
is not associated with Src coactivation and does not
involve integrin signaling. In fact, angiostatin
probably causes a flawed, integrin-independent
activation of FAK that perturbs the ordered
turnover of focal adhesion contacts induced by
VEGF and FGF-2. Angiostatin-induced endothelial
apoptosis may be an important mechanism by
which angiostatin modulates the angiogenic
process.
5. IDENTIFICATION OF PROTEIN
INTERACTING SITES
Understanding protein function is key to know
how complex biological systems operate in normal
physiological situations and to understanding how
these systems are dysregulated in pathological
conditions. Identifying the function of a protein can
be very difficult to achieve, particularly for novel
proteins identified, for instance, by genome-
sequencing technologies or by immunological or
proteomic approaches. Many clues for functionality
can be provided by a careful analysis of the
expression patterns of the protein in a variety of
circumstances. In a general sense, proteins that
directly interact with each other can be expected to
participate in the same cellular processes. On this
basis, the finding that a protein of unknown
function binds to a protein of known function
provides a significant clue to the cellular pathway
in which the unknown protein participates (Oliver,
2000). A widespread configuration for targeting
proteins is that based on direct binding, which
consists of immobilizing the target protein on a
solid support, mixing the source of possible ligand
with or passing it over the immobilized protein and,
after a washing step(s), eluting and characterizing it
by some other analytical method. The most common
form of this analysis is immunoprecipitation (Coligan
et al., 1999). Drawbacks of this type of analysis
include the possibility of nonspecific binding, a
general lack of sensitivity and difficulties of
immunoprecipitating noncytosolic proteins
complexes or proteins in low abundance.
Phage display is a powerful method for obtaining
small-peptide ligands for essentially any protein of
interest. In many cases, these binding peptides act as
antagonists or even agonists of natural protein
functions. This method is accelerating the pace of
research by enabling the study of complex protein-
protein interactions with simple methods of
molecular biology. While most extracellular protein-
protein interactions involve large epitopes formed by
discontinuous regions of primary sequence, there are
numerous intracellular interactions that depend on the
specific recognition of small, continuous epitopes
within large proteins. Indeed, many distinct families
of intracellular protein domains have evolved to
recognize linear epitopes with particular
characteristics (Pawson, 1995). Proline-rich
sequences are recognized by at least two different
families: Src homology 3 (SH3) domains (Ren et al.,
1993), and WW domains (named for two highly
conserved tryptophan residues within the family
consensus) (Chen and Sudol, 1995). Another
common binding motif consists of phosphotyrosine-
containing sequences, which are recognized by Src
homology 2 (SH2) (Songyang et al., 1993) and
phosphotyrosine-binding (PTB) domains (Kavanaugh
and Williams, 1994). PDZ domains (so-called
because they were first recognized in the proteins
postsynaptic density-95, discs large, and zonula
occludens-1) predominantly bind to specific C-
terminal sequences (Cowburn, 1997). These and
other peptide-binding domains are small compact
modules that are usually found imbedded in larger
proteins, often with other modules of their own or
different types. Acting in concert, multiple modules
can bind multiple partners and thus assemble and
localize intricate signaling complexes and
intracellular architecture. The two-hybrid assay has
been proved to be an efficient technique for finding
new protein interactions (Fields and Song, 1989;
Drees, 1999). However, the system also has a
reputation for producing a significant number of false
positives that require cumbersome analysis to
separate the true interactions from the false positive.
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More recently, methods such as phage display have
come into wide use to rapidly create extensive
genetic diversity and impose highly controlled and
focused selective pressures to obtain interesting
peptide and protein functions. With all the
approaches mentioned, confirmation of candidates
by secondary assays is critical.
5.1 Phage Display
Phage display technology has had a major
impact on immunology, cell biology, drug
discovery and pharmacology. It is an extremely
powerful tool for selecting peptides or proteins with
specific binding properties from a vast number of
variants. The principle that exogenous peptides can
be displayed on the surface of filamentous
bacteriophage was first described by Smith in the
mid  1980s  (Smith, 1985).   Phage display involves
the expression of proteins, including antibodies, or
peptides, on the surface of filamentous phage. This
is accomplished by the incorporation of the
nucleoid sequence into a phage or phagemid
genome as a fusion to a gene encoding a phage coat
protein. This fusion ensures that as phage particles
are assembled, the protein to be displayed is
presented at the surface of the mature phage, while
the sequences encoding it are contained within the
same phage particle.
5.1.1 Filamentous phage structure and life
cycle
The filamentous phage particles known as ft
include strains M13, f1 and fd. Fd consists of a
single-stranded (ss)DNA that is enclosed in a protein
coat forming a viral particle and be able to infect
E.Coli via F pili. The Fd phage particle is
approximately 6.5 nm in diameter and 930 nm in
length. The mass of the particle is approximately 16.3
MD, of which 87% is contributed by protein.
Bacteriophages infect a variety of gram negatives
using pili as receptors. The bacteria are not lysed by
the phage but secrete multiple copies of phage
displaying a particular insert. The entire genome of
the phage consists of 11 genes. Four minor proteins
are found at the tips of the virion, of which pIII and
pVIII are the most commonly used to display peptide
and antibody libraries (Hoess, 2001; Rodi and
Makowski, 1999; Vaughan et al., 1998; Griffiths and
Duncan, 1998; Zwick et al., 1998; Dall'Acqua and
Carter, 1998; Raag and Whitlow, 1995; Winter et al.,
1994). A viable phage expresses about 2700 copies of
gene 8 protein (g8p  or pVIII, a 50 aa  residue protein
that is also known as the major capsid protein) and
three to five copies of the gene III (g3)-encoded
adsorption protein (g3p or pIII, a 406 aa protein that
is one of the three minor coat proteins of the
filamentous phage) on its tip (Figure 17). The
advantage is that quite large peptide and protein
inserts can be incorporated into pIII without loss of
phage infectivity, and the exogenous peptide is
exposed, facilitating high-affinity binding. We have
applied phage display technology using an fd-based
vector called fUSE5, which consists of a single phage
chromosome bearing a single gene III, which accepts
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foreign DNA inserts and encodes a single type of
pIII molecule. The foreign peptide encoded by the
insert is therefore displayed on all three to five pIII
molecules on a virion (Scott and Smith, 1990).
Filamentous phage do not produce a lytic
infection in E. Coli, but rather induce a state in
which the infected bacteria produce and secrete
phage particles without undergoing lysis. Infection
is initiated by attachment of the phage g3p to the f
pilus of a male E. Coli. The f pilus is a protein tube
assembled from pilin subunits in the cytoplasmic
membrane and extends from the membrane out into
the medium. Only the circular phage ssDNA enters
the bacterium, where it is converted by the host
DNA replication into the double-stranded plasmid-
like replicative form (RT). The RT undergoes
rolling-circle replication to make ssDNA and also
serves as a template for expression of the phage
proteins g3p and g8p. Phage progeny are assembled
by packing of ssDNA into protein coats and
extruding through the bacterial membrane to the
medium.
5.1.2 Screening phage display libraries
Considerable progress has been made in the
construction of phage display random peptide
libraries and in the development of screening
methods (Barbas, 1993). Most screening procedures
that use phage are based on affinity selection and
involve the following fundamental steps: 1) A
library is amplified and phage particles produced,
2) phage particles are exposed to a target protein for
which a binding is sought; 3) non-binding phage
are removed by washing, and 4) binding phage to
the target molecule are eluted and infected into a
host bacteria to amplify the selected phage clone
(Figure 18). These bio-panning rounds are repeated,
typically three to six times until an enriched
population of binders is selected. The sequence of a
binding peptide is determined by sequencing the
part of the phage genome that encodes the peptide.
Finally, the insert can be reproduced as a
recombinant or synthetic peptide. Using this
methodology, specific and selective ligands to
target receptors can be found.
5.1.3 Use of phage display for in vitro and in
vivo screenings
Figure 18.. Biopanning consists of four steps: (1) screening of
phage display library on specific target, (2) elution of bound
phages from target, (3) amplification of eluted phages, and (4)
sequencing of DNA insert (Koivunen et al., 1999).
In recent years, phage display has been widely
used for a selection of peptides and proteins that bind
target molecules. Extensive data have been generated
based on the use of phage libraries to identify
extracellular integrin ligands (Koivunen et al., 1999).
For example, RGD-containing peptides with high
affinity for av integrins have been isolated by phage
display and shown to be useful tools for targeting
tumor vasculature in vivo (Koivunen et al., 1995;
Pasqualini et al., 1997; Zetter, 1997). Phage-
displayed peptides libraries have also been used to
determine the epitope of an antibody. Antibodies
recognize small peptide motifs based on only three or
four conserved residues. Based on the epitope motif
revealed by phage display, it is possible to delineate
the region on a protein recognized by the antibody
(Scott and Smith, 1990; Cwirla et al., 1990).
Characterization of epitopes of antibodies involved in
autoimmune disorders may field important
information about the immunogenic mechanisms of
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disease (Cortese et al., 1996). There are also other
molecules in the immune system that recognize
short peptide sequences. The function of the major
histocompatibility (MHC) molecules is to display
short peptides in the cell surface. Based on peptidic
sequences bound to MHC molecules, the immune
system can recognize when the cell becomes
abnormal or has been invaded by microorganisms
harmful to the host. Phage display has been used to
delineate the peptide structures recognized by
individual MHC molecules (Hammer et al., 1992;
Davenport et al., 1996; Kurokawa et al., 2002). In
addition, phage antibodies are a special type of
phage-display construct in which the displayed
peptide is an antibody molecule, or more exactly, a
domain of the antibody molecule that includes the
site that binds antigen. A phage-antibody library
includes billions of clones, displaying billions of
antibodies with different antigen specificities
(McCafferty et al., 1990; Barbas et al., 1991;
reviewed in Rader and Barbas, 1997). Surface
display of the antibodies allows for affinity
selection by antigen in vitro, an artificial analogue
of selection by antigen in natural immunity.
Phage display has also allowed the
identification of specific ligands to cell surface
receptors using as bait cells expressing integrins,
the urokinase receptor (Goodson et al., 1994), and
the melanocortin receptor-1 (Szardenings et al.,
1997). Specific ligands have also been found for
fibroblasts and myoblasts (Barry et al., 1996),
endothelial cells (Nicklin et al., 2000), neutrophils
(Mazzucchelli et al., 1999), T cells (Engelstadter et
al., 2000), and head and neck carcinoma cells
(Hong and Clayman, 2000), among others (Brown,
2000). Despite this relative success, cell-surface
selection of phage-displayed peptides has been
plagued by technical difficulties. First, a high
number of non binder and non-specific binder
clones are recovered when phage libraries are
incubated with cell suspensions or monolayers.
Second, removal of the background binding by
repeated washes is both labor intensive and
inefficient. Third, cells and potential ligands are
frequently lost during the many washing steps
required. For all these reason we pursue a new
approach for cell panning that leads to fast
identification of selective and specific peptide
binders from phage libraries.
Phage display can also be used for in vivo
selection of phage that home specifically to a target
organ by means of a surface-displayed peptide
binding. Different peptide motifs binding specific
markers have been recovered from brain, kidney,
lung, skin, pancreas, intestine, uterus, adrenal gland,
retina and tumor xenografts in mice (Aquiline and
Roulette, 1996; Remote et al., 1998; Pauline et al.,
1997; Burg et al., 1999; Arap et al., 1998; Koivunen
et al., 1999; Liu, 2003). These findings have
expanded the knowledge of functional phenotypes of
cells forming the endothelium based on
protein–protein interactions, a field that can be
defined as “vascular proteomics” (Trepel et al.,
2002). Peptides isolated by phage display can also be
peptidomimetic drug leads (Martens et al., 1995;
Sparks et al., 1995; Wrighton et al., 1996; koivunen
et al., 1999). The isolated peptide ligands have been
used as carriers for targeted delivery of cytotoxic
drugs (Arap et al., 1998), proapoptotic peptides
(Ellerby, 1999), cytokines (Curnis et al., 2000) gene
therapy (Wickham, 1997; Trepel et al., 2000), and
imaging agents (Hong and Clayman 2000), in tumor
mouse models.
5.2 Benefits of phage display in molecular-
recognition studies
Phage-display technology has matured to the
point where it is now a powerful tool in the
postgenome era of biology. Phage-display constructs
of genetically tagged peptides, proteins or protein
fragments allow researches to convert pools of
combinatorial nucleotides, mRNAs or fragmented
genomes into populations of viruses that contain the
nucleotide coding for the elements displayed on their
viral surfaces. In a general sense, proteins that
directly interact with each other can be expected to
participate in the same molecular processes. The
physical linkage of phenotype and genotype intrinsic
to a phage-display library makes it possible for the
binding properties of the displayed elements to be
identified, modified and/or optimized in a matter of
weeks with standard laboratory resources.
Yeast and other two-hybrid technologies (Toby
and Golemis, 2001) offer an alternative strategy for
identifying protein-protein interaction. Two-hybrid
techniques share a common shortcoming with phage-
display techniques. They are both limited by the
biology of the system underlying their
implementation. Although yeast two-hybrid has a
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proven track record in identifying candidate
interacting partners in any given proteome (Uetz
and Hudghes, 2000; Walhout and Vidal 2001),
phage display has some advantages in mapping
protein-protein interactions due, in part, to the
enormous diversity of sequences capable of being
displayed by bacteriophage. Even if it has been
possible to generate and screen combinatorial
peptide libraries by yeast two-hybrid screening,
because of the intrinsically inefficient nature of
transforming yeast, the libraries are of lower
complexity and have not been of much utility in
mapping protein-protein interactions (Table 11).
Another advantage to phage display technology
is that it is possible to screen combinatorial peptide
libraries for peptide ligands to target not traditionally
used in yeast two-hybrid screening. For example, one
can affinity-select peptides that bind to small-
molecule drugs, such as taxol, 2-methoxyestradiol or
doxorubicin (Rodi et al; 1999; Arap et al., 1998).
These studies have demonstrated that the selected
peptides have primary structures similar to peptide
loops involved in drug binding to known targets;
such information is invaluable in designing drug
candidates that have fewer side effects. Random
phage-display peptide libraries, in combination with
other combinatorial methods, have offered an
excellent approach to search for potent mimetic
proteins and minimal peptide sequences retaining
activity.
Resumen introducción
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CÉLULAS: MACRÓFAGOS Y CÉLULAS
ENDOTELIALES.
Los macrófagos que forman parte de las células
hematopoiéticas, y las células endoteliales
probablemente compartan un progenitor común. A
este precursor común se le ha denominado
hemangioblasto . Las células sanguíneas aun
indiferenciadas y los precursores de las células
endoteliales comparten los marcadores celulares
CD34, GATA-2. LMO-2 y SCL, además de los
receptores tirosina kinasa: VEGFR-2, Tie-1 y Tie-2.
Los macrófagos forman parte del sistema
fagocítico mononuclear, que a su vez engloba una
serie de células (monoblastos, promonocitos,
monocitos y macrófagos) y una de sus funciones es
la fagocitosis. A diferencia de otras células del
sistema inmunitario, tales como los linfocitos B y T,
los macrófagos o bien se encuentran proliferando, o
bien se activan y dejan de proliferar, pasando así a
ejercer sus funciones características.
Los macrófagos son originados en la médula
ósea y emigran a todos los tejidos del organismo,
donde constituyen junto con los neutrófilos el mayor
sistema antimicrobiano del cuerpo. Este proceso de
emigración puede estar regulado por las necesidades
del organismo (inflamación, isquemia, necrosis,
apoptosis, etc.). A nivel local se produce una
disminución del flujo sanguíneo y, por tanto, se
asegura que los monocitos y las células del endotelio
interaccionen más fácilmente, favoreciendo así la
extraversación de los monocitos a los tejidos.
Los procesos de proliferación celular son el
conjunto de fenómenos que conducen a una célula a
dividirse en dos, manteniendo cada una de las
células hijas toda la información contenida en su
predecesora. Los procesos de división celular están
finamente regulados tanto por factores intrínsicos
(ciclo celular) como extrínsecos (factores de
crecimiento o señales mitogénicas). En el caso de
los monocitos, los macrófagos y sus progenitores
inmediatos, los procesos de proliferación y
supervivencia están regulados por el factor de
crecimiento específico que es el M-CSF
(Macrophage-Colony Stimulating Factor).
La activación del macrófago es un proceso complejo
y estrictamente controlado que consiste en una serie
de alteraciones morfológicas, bioquímicas y
funcionales que culminan en un aumento del
potencial de la célula para ejecutar funciones
complejas, como la presentación de los antígenos, la
lisis de las células tumorales o la actividad
bactericida. Los agentes más potentes en la
activación de los macrófagos son el interferón
gamma (IFN-g) y el lipopolisacarido (LPS), aunque
también otros agentes como el M-CSF, el GM-CSF
(Granulocyte Macrophage-Colony Stimulating
Factor), la IL-1 (Interleucina-1), IL-2, IL-4 y TNF-a
(Tumor Necrosis Factor-a) pueden inducir algunos
aspectos de la activación.
En los macrófagos, el LPS induce la síntesis de
citocinas tales como TNF-a, IL-1, IL-6, IL-8, IL-10,
IL-12, IFN-a/b , TGF-b (Transforming Growth
Factor-b), metabolitos del ácido araquidónico y
otros lípidos bioactivos, péptidos quimiotácticos
como MIP-1a (Macrophage Inflammatory Protein-
1a ), y derivados reactivos del oxígeno y del
nitrógeno. La mayor parte de los productos
inducidos por el LPS actúan de forma autocrina
sobre los propios macrófagos. También se ha
descrito un efecto negativo del LPS sobre algunas
actividades inducidas por el IFN-g, tales como la
expresión de las moléculas del MHC II (Complejo
Principal de Histocompatibilidad de clase II) o la
expresión de los receptores scavenger. Mientras que
una respuesta inflamatoria local generada por el LPS
es beneficiosa para la lucha contra las infecciones
bacterianas, la repuesta inmunológica generalizada y
exagerada debido a la presencia de LPS en la
circulación puede conducir a un choque endotóxico,
capaz de causar la muerte del individuo.
El IFN-g es una citocina que juega un papel
crítico como modulador de la respuesta inmunitaria.
Todas las células del organismo poseen receptores
específicos para el IFN-g, lo que condiciona que esta
citocina tenga un cierto efecto pleitrópico sobre
distintos tipos celulares. Pese a este efecto
pleitrópico, la diana por excelencia del IFN-g son los
monocitos y los macrófagos, sobre los que actúa
como principal inductor del proceso de activación.
En las células, IFN-g induce la expresión de los
genes del MHC II, promoviendo la función
presentadora de antígeno de los macrófagos.
Además, induce la síntesis y secreción de citocinas,
tales como TNF-a , IL-1b , IL-6 e IL-12, y de los
componentes del sistema del complemento. En
particular, la inducción de la síntesis de IL-12
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representa un mecanismo de retroalimentación
positivo en el contexto de la inmunidad específica
mediada por células, ya que esta interleucina actúa
como un potente inductor de la generación y
proliferación de linfocitos T CD4+ del subtipo Th1.
A pesar de que los macrófagos juegan un papel
clave en la fagocitosis de los cuerpos apoptóticos o
en la inducción de apoptosis sobre otros tipos
celulares, poco se conoce acerca de los estímulos
que modulan la apoptosis de los propios macrófagos.
Estas células requieren factores de crecimiento
específicos para mantener su viabilidad. La ausencia
del factor de crecimiento M-CSF induce la muerte
por apoptosis.
Las otras células derivadas del progenitor
común hemangioblasto, son las células endoteliales.
Estas células cubren la superficie interior de los
vasos sanguíneos formando el endotelio. Se ha
hecho evidente en los últimos años que el endotelio
es dinámico y enormemente heterogéneo. El
endotelio es un órgano diseminado que posee
capacidad secretora vital, además de funciones
sintetizadoras, metabólicas e inmunológicas.
Las células endoteliales juegan un papel
importante como mediadoras celulares controladoras
del desarrollo vascular y del sistema vascular
embrionario, donde desempeñan un papel crítico en
el transporte metabólico de desechos y nutrientes.
Además transmiten señales hormonales hacia y
desde los tejidos en desarrollo a través de los
receptores unidos a la membrana o bien usando los
receptores específicos directos que regulan las
interacciones célula-célula y de la célula con la
matriz extracelular. Los vasos de nueva formación
en el adulto se producen principalmente en la
angiogénesis. Esta consiste en la formación de
nuevos vasos que se ramifican a partir de los ya
existentes (generalmente una vénula) y se debe a la
actividad propia de las células endoteliales. También
puede ocurrir una vasculogénesis.
Las células endoteliales son una población muy
heterogénea. Se encuentran diferencias tanto entre
los endotelios de distintas especies, como dentro de
los diferentes tipos de vasos. También hay
diferencias entre las células endoteliales que derivan
de las distintas microvasculaturas.
Las principales funciones de los endotelios son
la regulación de la homeostasis, el tono vascular y el
crecimiento. Además existe una regulación
endotelial de la respuesta inflamatoria, donde las
moléculas de adhesión celular desempeñan un papel
importante, y se expresa tanto en células endoteliales
como en células sanguíneas. También, la sobre
expresión de las citocinas inducidas por las
moléculas de adhesión en el endotelio puede
modular la transducción de las señales. Finalmente,
las células endoteliales tienen un papel primordial en
el fenómeno de la angiogénesis, y se sabe que este
fenomeno puede ser el principal en la mayoría de las
condiciones patológicas, tal y como ocurre en la
retinopatía diabética proliferativa, la artritis
reumatoide y en la vascularización de los tumores.
La angiogénesis es un factor fundamental para la
reproducción, el desarrollo y la reparación tisular.
Todo esto depende del crecimiento regulado de los
vasos sanguíneos ya que si no se controla conduce a
la situación patológica que mantiene la evolución de
las enfermedades neoplásicas y no neoplásicas.
Las células endoteliales son uno de los mayores
componentes de la vasculatura. Estas células
altamente metabólicas son capaces de sintetizar y
secretar una gran variedad de moléculas
biológicamente activas, que son importantes para la
regulación del tono vascular y del flujo sanguíneo.
Esto es importante en la modulación de las repuestas
inflamatorias e inmunológicas, y en la regulación del
desarrollo vascular. En particular, las células
endoteliales sintetizan y liberan a la circulación un
gran número de factores de crecimiento incluyendo
interleucinas, factores de crecimiento e interferones
que modulan el crecimiento y la proliferación de las
células hematopoiéticas.
La activación de las células endoteliales como
respuesta al microambiente en el que se encuentran
esta asociada a cambios en el fenotipo de dichas
células. Estos son los procesos de transdi-
ferenciación del fenotipo constitutivo, que se
producen con el fin de cubrir las necesidades locales
y adaptarse a los nuevos requerimientos funcionales.
En estos procesos de adaptación están involucradas
las moléculas de superficie así como las citocinas,
que juegan un papel crítico en las condiciones
patológicas como puede ser la inflamación, la
angiogénesis tumoral o la cicatrización.
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Los procesos de vasculogénesis y angiogénesis
requieren la interacción de las células endoteliales
con la matriz extracelular a través de las integrinas.
La señalización afecta a los elementos del
citoesqueleto que controlan la morfología de las
células endoteliales y las interacciones célula-célula
que condicionan la estructura tridimensional de los
tubos de los vasos sanguíneos. Las actividades
celulares asociadas con la invasión tumoral implican
una reducción de la adhesión célula-célula, una
alteración de la adhesión matriz-célula, de la
migración, de la supervivencia ectópica, y de la lisis
de la matriz extracelular. Esto permite al endotelio
formar barreras para la acumulación de solutos,
macromoléculas y leucocitos entre el espacio
intersticial y el lumen del vaso, facilitando así la
posible formación de los nuevos vasos sanguíneos.
Muchos estudios indican que los receptores de
la matriz extracelular expresados en las células
endoteliales son críticos para mantener correc-
tamente la función de estas células. La familia mejor
estudiada de estos receptores son las integrinas, las
cuales tienen dos funciones principales, mantener la
unión célula-célula o célula-matriz y transferir
información al interior celular que puede resultar
tanto en la proliferación como en la muerte celular.
MATRIZ EXTRACELULAR
La mayoría de las células de los organismos
pluricelulares están en contacto con una intrincada
trama de macromoléculas extracelulares que
constituyen la sustancia o la matriz extracelular. Esta
es un componente de los tejidos básicos, y
comprende toda la sustancia que se encuentra
rodeando a las células en los tejidos. En el ámbito
molecular la matriz extracelular esta integrada por
proteínas y polisacáridos que se segregan localmente
y se ensamblan formando una trama organizada en
el espacio extracelular de la mayoría de los tejidos.
Además de actuar como cemento biológico universal
también forma estructuras altamente especializadas
como el cartílago, los tendones, las láminas básales,
los huesos y los dientes.
Las proteínas que componen la matriz
extracelular incluye los colágenos, las glicoproteínas
(no-colágenas) como por ejemplo la fibronectina, y
los proteoglicanos. Todos estos componentes se
organizan formando una red fibrosa que
proporcionan la fuerza mecánica y la elasticidad
necesaria para la adhesión y la migración celular.
Las glicoproteínas se dividen en dos grupos según su
función, por un lado están las proteínas adhesivas
como la fibronectina, la vitronectina y la laminina,
las cuales forman conexiones con otras moléculas de
la matriz extracelular y las células mediante las
integrinas que son los receptores específicos. El
segundo grupo de glicoproteínas esta formado por
las denominadas proteínas matricelulares como la
tenascina, la SPARC (secreted protein acidic and
rich in cysteine), la trombospondina y la
osteonectina. Estas proteínas son secretadas e
interactúan con otros constituyentes de la matriz
extracelular, con múltiples receptores de superficie
celular y además con los factores de crecimiento,
modulando así las interacciones de la matriz con las
células.
Los colágenos son una familia de proteínas
estrechamente relacionadas entre ellas que pueden
agregarse y generar filamentos. Junto con otros
componentes de la matriz extracelular inducen la
adhesión celular, activan las vías de señalización
intracelular y regulan las actividades de varios
factores de crecimiento y de otras proteínas.
Los proteoglicanos son macromoléculas
formadas por una proteína central, a lo largo de la
cual se asocian, por su extremo terminal, numerosa
moléculas de glucosaminoglicanos sulfatados. Estas
macromoléculas están representadas en todos los
tejidos. Existe una enorme variedad de
proteoglicanos dependiendo del tipo y tamaño de la
proteína central y del tipo, número y longitud de los
glucosaminoglicanos asociados a ella. El más
pequeño es la decorina, que solo contiene una
molécula de glucosaminoglicano y el más grande el
agrecan que contiene alrededor de 100.
Funcionalmente, los proteoglicanos participan en la
adhesión célula-célula y célula-matriz extracelular,
en procesos de biomineralización, y son reguladores
de la migración y de la plasticidad celular.
Recientemente los proteoglicanos se han clasificado
en tres grandes grupos, SLRPs (small leucine-rich
proteoglycans), los hailectanos y los proteoglicanos
de las membranas. A su vez, estos dos últimos se
agrupan formando proteoglicanos modulares,
llamados así porque están estructuralmente
compuestos por diferentes módulos.
La decorina es un proteoglicano pequeño de
unos 38 kDa. Los efectos inducidos por esta proteína
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son mediados en parte por la interacción específica
entre la núcleo proteico y el receptor del factor de
crecimiento epitelial (EGF), desencadenando una
cascada de señalización que da como resultado la
activación de las MAPKs (mitogen activated protein
kinases), la movilización del calcio intracelular y el
aumento de los niveles de p21Waf1 motivando así una
supresión del crecimiento celular.
Una de las funciones más importantes de la
decorina es su capacidad para regular la
proliferación celular. Se han encontrado niveles
altos de decorina en las células quiescentes. Por el
contrario, la expresión de la proteína es baja cuando
las células están proliferando activamente o en las
células transformadas. Estas observaciones son
consistentes con el papel inhibidor del crecimiento
que ejerce la decorina. Este papel antiproliferativo
de la decorina puede tener un significado muy
importante en los distintos estadios de las
enfermedades tales como la fibrosis y el cáncer. Se
ha descrito también que la decorina podría modular
la actividad del TGF-b uniéndose activamente a esta
citocina, que a su vez participa en el control de la
proliferación, adhesión, diferenciación y deposición
de la matriz celular.
RECEPTORES DE LA ADHESIÓN CELULAR
Los CAMs (cell adhesion molecules) son
glicoproteínas ubicadas en la superficie celular que
constituyen los receptores celulares, mediante los
cuales se efectúan las interacciones específicas
célula-célula y célula-matriz extracelular. Todas las
funciones biológicas mediadas por estos receptores
requieren, o son influenciadas por estas
interacciones, especialmente durante la
embriogénesis, en la morfología celular, en el
desarrollo tisular, en la migración de las células, en
los procesos inflamatorios e inmunológicos, la
invasión celular en el tumor y en otros muchos. Las
interacciones de las células con las células
adyacentes y con la matriz celular que las rodea esta
mediada por diferentes clases de receptores de
adhesión celular, entre ellos las integrinas, las
caderinas, y los miembros de la familia de las
selectinas y la superfamilia de las inmunoglobulinas.
Las caderinas son una familia de glicoproteínas
transmembranales que median la adhesión célula-
célula de forma dependiente de calcio. Esta familia
esta dividida en cuatro grupos, las caderinas
clásicas, las desmosales, las protocaderinas y las
atípicas. Muchas de estas se caracterizan por ser
especificas de tejido, como la caderina-E que fue
identificada en el epitelio, la endotelial caderina-VE
en la vasculatura, o bien la neuronal, caderina-N.
Las propiedades de adhesión, con actividad
homofílica y de gran especificidad de interacción
con un determinado tejido revelan un posible papel
en la formación y mantenimiento de los tejidos en
que se hallan.
La superfamilia de las inmunoglobulinas esta
compuesta por una gran variedad de glicoproteínas
mayoritariamente expresadas en la superficie
celular. Típicamente tienen un dominio extracelular
muy largo cuya parte amino terminal contiene los
dominios de las inmunoglobulinas. Además,
contienen un segmento simple de hélice como
dominio transmembranal y una cola citoplasmática.
Estas moléculas portadoras de dominios de
inmunoglobulinas median la adhesión que se
caracteriza por ser independiente de calcio y
participan en distintas funciones celulares como la
organización del citoesqueleto, la endocitosis, la
migración, el control del crecimiento celular, la
respuesta inmunitaria, además son receptores
víricos, participan en las reacciones inmunológicas y
en la progresión tumoral.
Las selectinas es una familia de tres proteínas
(selectina L, E y P) que son receptores
transmembranales de adhesión y están involucradas
principalmente en la regulación de los leucocitos y
su unión a las células endoteliales. El dominio
amino termina l , que es ta expues to
extracelularmente, caracteriza a esta familia de
proteínas que unen carbohidratos como lectinas. La
selectina L se expresa en los leucocitos y los
monocitos, y media el alojamiento de los linfocitos
en los nódulos linfáticos. La selectina E se expresa
en las células endoteliales activadas por citocinas.
La selectina P se expresa en los gránulos secretorios
de las plaquetas y en el endotelio estimulado.
Las integrinas son receptores heterodiméricos
de membrana, compuestos por una subunidad a y
una subunidad b que median las interacciones
célula-célula y célula-matriz extracelular. Las 18
subunidades a y las 8 b descritas interaccionan de
manera no covalente y restringida para formar 24
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heterodímeros distintos. Cada una de estas 24
integrinas cumple una función absolutamente
específica. Estas integrinas se unen a su ligando de
manera que es dependiente tanto de la afinidad como
de la avidez y esta influenciada por la conformación
del propio ligando y la capacidad de interaccionar y
de hacer multímeros con las moléculas preexistentes
de la matriz celular. Por esta razón, los distintos
ligandos, o las distintas formas de un determinado
ligando pueden transmitir señales diferentes a través
de la misma integrina. Las integrinas son receptores
transmembranales que están ampliamente
distribuidos. La porción extracelular interactúa
directamente con las moléculas de la matriz
extracelular como la fibronectina, la laminina, la
vitronectina y la tenascina, además de diferentes
proteínas plasmáticas, y de otras proteínas de la
superficie celular y patógenos microbianos. A su
vez, la porción intracelular interactúa con la actina
de citoesqueleto a través de las proteínas
intermediarias que principalmente son la a-actina, la
talina, la tensina y la vinculina.
Las integrinas son capaces de transmitir señales
de manera bidireccional. Esta señalización esta
mediada por las integrinas hacia el interior celular y
la señalización que proviene del interior de la célula
después de una previa activación de las integrinas
por la unión al ligando. La subunidad b es la
principal encargada de procesar esta señalización
bidireccional. Muchas de las subunidades b tienen
un dominio citoplasmático muy pequeño que consta
de unos 60 amino ácidos, excepto la subunidad b4
que tiene alrededor de 1000, que además contiene
dos pares de repeticiones FN (fibronectin) tipo III
que están separadas por un segmento conector. Se ha
descrito que los dominios citoplasmáticos de las
subunidades b1, b3 y b5 son suficientes para iniciar
la transmisión de señales. La subunidad b5 es
estructuralmente y funcionalmente única respecto a
las otras subunidades, además de haber sido descrita
como reguladora de la emigración y proliferación
celular.
Debido a que las integrinas no tienen por ellas
mismas capacidad enzimática, para la señalización
se basan en la unión a otras moléculas que sí poseen
estas propiedades. La parte citoplasmática de las
subunidades b tienen la capacidad de unirse a
numerosas moléculas, las cuales en muchos casos
son uniones específicas para cada subunidad. Entre
ellas cabe destacar la unión de la subunidad b1 a
FAK (focal adhesion kinase), a paxilina, a a-actina,
a talina, a miosina, a Grb2 (growth factor receptor-
bound protein 2). La subunidad b2 es conocida por
interaccionar con ILK (integrin-linked kinase) y con
citoadhesina-1. La cola citoplásmica de la b3 se une
a la b3-endoxina, a ILK, a la miosina y al Shc (Src
homology type 2). Hasta ahora sólo la TAP20 (theta-
associated prteoin 20) se ha asociado exclu-
sivamente a la subunidad b5. Todas estas uniones
permiten la transmisión de señales de manera
bidireccional a través de las membranas celulares.
La función primaria de las integrinas es
mantener la adhesion entre las células y de éstas con
los componentes estructurales de los tejidos de
sostén que las rodean. Dichas uniones se forman y se
refuerzan entre sí, en una secuencia que se inicia con
el contacto del receptor con una molécula en el
exterior de la célula. Al añadirse más uniones de este
tipo, se consolida una estructura compleja y firme,
llamada placa de adhesión focal. La unión de las
integrinas a determinadas moléculas presentes en la
matriz celular y las láminas basales, como la
laminina y el colágeno modifica la actividad de las
células epiteliales, al modular la expresión génica,
regulando así los procesos de emigración, la mitosis
y la apoptosis. Este mecanismo de muerte celular
programada o apoptosis se desencadena cuando la
célula pierde sus conexiones con las demás y con el
intersticio circundante. Cada vez hay más evidencias
experimentales del papel de regulación de la
apoptosis en el cual participan las integrinas. En los
últimos años se han descrito dos modelos de
apoptosis en los que las integrinas actúan de forma
directa. El primero se desencadena cuando las
células pierden el contacto, fenómeno denominado
anoikis. En el segundo, las integrinas no unidas al
ligando pueden interaccionar directamente con las
caspasas y promover apoptosis, un fenómeno
conocido como muerte mediada por integrinas.
VIDA Y MUERTE CELULAR
El balance entre la supervivencia y la muerte
celular en el organismo es esencial para procesos
fisiológicos como el desarrollo y el funcionamiento
del sistema inmunitario en los que es necesario un
estricto control del número de células. Las
alteraciones de este balance pueden desencadenar
una serie de consecuencias patológicas. Las
enfermedades como el Alzheimer y el Parkinson
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están relacionadas con anomalias en la mortalidad
de las células neuronales. Debido al papel que la
muerte celular tiene en muchas enfermedades,
incluyendo el cáncer, se ha dedicado una extensa
investigación a la regulación de estos procesos
apoptóticos.
El término apoptosis es usado para definir cómo
mueren las células en determinadas condiciones
fisiológicas y patológicas. Morfológicamente, la
apoptosis se caracteriza por la condensación de la
cromatina nuclear, la segmentación del núcleo, la
pérdida de la estructura de los orgánulos del
citoplasma, y la formación de vesículas en la
membrana. Todo ello da lugar a la desintegración
celular y a la formación de los cuerpos apoptóticos,
los cuales a su vez serán fagocitados por los
macrófagos, sin pérdida alguna del contenido
celular, aún activo, y evitando así inflamación y
daño tisular. Se le da la definición de muerte celular
programada por el requerimiento de expresión
génica tras la estimulación celular. Las células del
sistema inmunitario expresan en su superficie celular
los "receptores para la muerte" que tras ser
activados por sus ligandos específicos transmitirán
señales de apoptosis. Esta cascada de señalización
incluye la activación de los complejos de cisteino-
aspártico proteasas denominadas "caspasas". Se han
descrito 10 caspasas en las células humanas que
provocan una degradación proteica bien definida
hasta llegar a la formación de cuerpos apoptóticos.
Algunas caspasas son llamadas "iniciadoras" porque
intervienen en la activación de otras caspasas y otras
"efectoras" del proceso catalítico, que actúan
degradando específicamente múltiples proteínas
celulares incluyendo endonucleasas, que son las
responsables directas de la fragmentación del ADN.
La activación de las caspasas, que existen en calidad
de procaspasas inactivas, se produce por diversas
vías en las que participan varios complejos
moleculares.
Los efectos de la muerte celular derivados de la
activación de las caspasas pueden ser
contrarrestados por la presencia de los inhibidores
de las caspasas. Muchas proteínas que previenen la
muerte celular a través de la inhibición de las
caspasas han sido agrupadas en la familia IAP
(inhibitors of apoptosis proteins). Dentro de la
familia IAP, la XIAP (proteína inhibidoras de
apoptosis ligada al cromosoma X) parece ser el que
tiene  más  importancia  y  ejerce  un estímulo   anti-
apoptótico más fuerte. Las IAP en mamíferos tienen
un amplio rango de bloqueo de la apoptosis que
incluye, los ligandos y los transductores de señales
de la familia de los receptores del TNF, los
miembros proapoptóticos de la familia del ced-
9/Bcl-2 y el citocromo c, además de múltiples
agentes quimioterapéuticos.
Los macrófagos juegan un papel importante es
la supervivencia y la muerte celular. Estas, al igual
que el resto de las células del organismo, requieren
factores de crecimiento que mantengan su
viabilidad. Entre ellos el más importante es el M-
CSF que es requerido tanto para la supervivencia
como para la proliferación. Por otro lado, existe un
gran número de substancias capaces de inducir la
muerte de los macrófagos, como son las substancias
minerales y ciertas drogas (bleomicina, gadolinium,
morfina, etc.,). Al igual que ocurre con otras células
del sistema inmunitario, existe una relación entre los
procesos de activación de los macrófagos y la
modulación de los procesos apoptóticos. También se
han descrito un efecto protector de la apoptosis en
monocitos humanos y en otras células del linaje
macrofágico por el tratamiento con citocinas como
el TNF-a, GM-CSF, IL-3, IL-1b.
Por su parte, las células endoteliales también
entran en apoptosis si se les retiran los factores de
crecimiento o bien en respuesta a otros estímulos
(por ejemplo la activación de Fas o el daño por
radiación). Como para otros tipos celulares se ha
hipotetizado que las interacciones de las células
endoteliales con su entorno puede ser crítico para su
supervivencia. La angiogénesis es totalmente
dependiente de la supresión de apoptosis en las
células endoteliales. La inhibición de la adhesión
puede inducir directamente apoptosis celular. Una
característica común de los inhibidores de
angiogénesis es la inducción de apoptosis en las
células endoteliales. Por lo tanto, es de gran
importancia comprender los mecanismos por los
cuales las células endoteliales están implicadas tanto
en la apoptosis como en la supervivencia. De esta
forma se podran desarrollar nuevas terapias, tanto de
inhibición de la angiogénesis para aquellos casos en
que la enfermedad sea dependiente de la
neovascularización (tumores, diabetes retinopatía,
etc) o estimular la angiogénesis en el caso de
isquemia en los tejidos.
Introduction
45
IDENTIFICACION DE DOMINIOS DE
INTERACCION DE PROTEINAS: PHAGE
DISPLAY
Para poder comprender completamente la
función de las proteínas, es importante entender los
complejos biológicos que se forman en condiciones
fisiológicas normales y después observar cómo se
pierde esta regulación en condiciones patológicas.
La identificación de asociaciones de proteínas puede
ser una tarea muy complicada de llevar a cabo
debido a la complejidad que tales interacciones
pueden tener. Una de las técnicas utilizada más
comúnmente para este tipo de análisis ha sido la
inmunoprecipitación. Sin embargo, la escasa
sensibilidad y la dificultad en inmunoprecipitar
proteínas no citosólicas y aquellas que son
especialmente poco abundantes ha motivado el
desarrollo de nuevos métodos para poder llevarse a
cabo la identificación.
El phage display es un método muy potente
para seleccionar pequeños péptidos que actúan como
ligandos para cualquier proteína de interés. En
muchos casos estos péptidos que se unen
específicamente a la proteína pueden actuar de
antagonistas o de agonistas de la función de la
proteína natural. El principio del phage display
radica en que péptidos exógenos pueden ser
expresados en la superficie de un bacteriófago
filamentoso, técnica descrita a principios de los años
80 por Smith. En las genotecas peptídicas
normalmente el péptido exógeno esta incorporado a
la proteína III del bacteriófago, que es la proteína de
infección en la bacteria que le proporciona una gran
estabilidad de expresión.
La utilización de esta técnica usando genotecas
peptídicas al azar permite la selección de péptidos
por afinidad. El proceso de selección conlleva
diferentes pasos, que se inicia con la amplificación
de las partículas fágicas, las cuales se exponen
posteriormente a la proteína de interés para la
que estamos buscando péptidos de unión. El fago no
unido se descarta y se infectan las bacterias con
los fagos que se han unido específicamente a la
proteína de interés. Todos estos pasos constituyen el
denominado “panning”. Para obtener mayor
especificidad el bio-panning es repetido entre 3 y 6
veces, la secuencia de ADN que codifica por el
péptido exógeno insertado en el bacteriófago se
determina por métodos de secuenciación y
finalmente el inserto puede ser reproducido como
proteína recombinante o péptido sintético.
El phage display se ha utilizado en los últimos
años para identificar un amplio rango de proteínas
que se unen específicamente a moléculas diana tanto
in vitro como en in vivo. Existe una amplia variedad
de aplicaciones para las que se pueden utilizar las
posibilidades de este método. Así el phage display
permite la identificación de ligandos que reconocen
receptores ya conocidos y se puede utilizar para
encontrar el epítopo de un anticuerpo que puede
proporcionar información importante acerca de los
mecanismos inmunológicos de una enfermedad.
También se ha utilizado para identificar ligandos de
receptores celulares. Sin embargo, esta última
aplicación ha tenido muchísimas dificultades para
ser aplicada por razones de afinidad del ligando al
receptor, además de la gran inespecificidad obtenida
de bacteriófago no unido específicamente, o bien la
pérdida de posibles uniones al incrementar la
astringencia de los lavados para evitar la gran
cantidad de bacteriófago unido no específicamente.
Por todo ello, nos hemos planteado desarrollar una
nueva estrategiaque nos facilite la separación de
complejos célula-bacteriófago del resto del
bacteriófago no unido a la superficie celular.
Últimamente, debido a la problemática de que
no todos los marcadores o moléculas encontradas en
modelos de ratones se han podido aplicar a las
terapias clínicas en humanos, se ha diseñado un
nuevo experimento usando phage display en
pacientes con el objetivo de poder seleccionar
marcadores específicos de los vasos de los distintos
órganos e identificar los ligandos in vivo.
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The overall objective of this study focuses on the description of certain mechanisms involved in cell
survival. We seek to elucidate molecular mechanisms involving soluble and insoluble extracellular
factors and their receptors. To achieve this goal we will use two cellular models, macrophages derived
from bone marrow and endothelial cells. Both cell types proliferate in the presence of growth factors
and can get activated in response to specific signals such as growth factor withdrawal. We will analyze
the response of these cells to soluble and insoluble ligands that modulate cell death and survival. In
addition, we intend to characterize cell surface components specifically involved in cell signaling and
describe mechanisms of receptor-dependent cell survival. For this purpose we will use phage display, a
powerful method used to obtain small peptide ligands to essentially any protein of interest.
The following specific aims are proposed:
Specific Aim 1: To analyze the molecular mechanisms involved in modulation of macrophage death and
survival by IFNg and the extracellular matrix protein decorin:
1.1. To study the ability of IFNg to protect macrophages against apoptosis induced by different
stimuli.
1.2. To analyze mechanisms of cell cycle regulation that mediate decorin-dependent cell
survival.
1.3. To analyze mechanisms of decorin-dependent cell survival through interactions with the
TGFb signaling pathway.
Specific Aim 2: Characterization and functional analysis of endothelial cell surface receptors that can
modulate proliferation and cell death
2.1. To dissect the integrin b5 signaling pathway by selection and analysis of peptides that bind
to the b5 cytoplasmic domain.
2.2. To characterize cell surface receptors involved in endothelial cell activation and
proliferation.
2.3. To isolate cell surface markers to the human vasculature by phage display.
